ID,title,status,study_type,observational_study_model,target_duration,sampling_method,fda_regulated_drug,fda_regulated_device
BTX-BCI-016-PRT,Breast Cancer Index (BCI) Registry,Recruiting,Observational,Case-Only,5 Years,Non-Probability Sample,No,No
2018-TJ-BCD,Diagnosis Value of SEMA4C in Breast Cancer,Not yet recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
Breast cancer,Role of Sorcin and Annexin A3 in Breast Cancer Patients,Unknown status,Observational,Case-Control,,Probability Sample,No,No
BC-BOMET,Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
241391,A Study to Identify Breast Cancer (IDBC),Unknown status,Observational,Cohort,1 Year,Non-Probability Sample,No,No
IL-TM-B1-01,Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
FH-Risk 2.0 Research Protocol,FH-Risk 2.0: Updating Breast Cancer Risk Estimates,Recruiting,Observational,Other,,Non-Probability Sample,No,No
ID-RPSBC-01-20201012,Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples,Recruiting,Observational,Case-Control,3 Months,Probability Sample,No,No
ANILERGİNN,Weight Loss and Breast Cancer,Not yet recruiting,Observational,Cohort,10 Years,Probability Sample,No,No
32155120.7.0000.0072,Breast Cancer Survivors: Main Physical and Psychosocial Problems After Completion of Treatment,Unknown status,Observational,Cohort,,Probability Sample,No,No
Yuan Shifang-1,Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device,Unknown status,Observational,Cohort,,Probability Sample,No,No
PI-2842,Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women,Completed,Observational,Cohort,,Probability Sample,No,No
NCC2985,Characteristics and Treatment Trends of Young Breast Cancer in China,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
260281,Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
V1 11.12. 2020 (C.I.R.E.C.),Onco-liq: Kit for Breast Cancer Diagnosis.,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CLM-INS-004,PERSONAL - Sleep In Breast Cancer,Completed,Observational,Cohort,,Probability Sample,No,No
miRNA in breast cancer,Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer,Not yet recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
MC1933,Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer,Recruiting,Observational,Case-Only,,Probability Sample,No,No
RADIOVAL,Clinical Validation of Radiomics Artificial Intelligence: Application to Breast Cancer Treatment Planning,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CE21096B,Factors Affecting Rehabilitation Time for Postoperative Complications Among Breast Cancer Patients,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
MicroRNA in breast cancer,Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients,Not yet recruiting,Observational,Case-Control,,Probability Sample,No,No
GEICAM/2016-04,Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk,"Active, not recruiting",Observational,Case-Only,,Probability Sample,No,No
BMIBC,Impact of Body Mass Index on Outcomes of Breast Cancer Management,Unknown status,Observational,Case-Control,,Probability Sample,No,No
3.0840453,Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53,Completed,Observational,Case-Control,,Probability Sample,No,No
HKG-KZ-BrCa-101,"Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC",Terminated,Observational,Case-Control,,Non-Probability Sample,No,No
Hibiscuss,"Breast Cancer Detection in Breast Surgical Specimens With the Histolog Scanner, Slide-free Confocal Microscope",Completed,Observational,Other,,Probability Sample,No,No
Pro00107118,A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer,Recruiting,Observational,Cohort,1 Year,Probability Sample,No,No
SNAPS Breast Cancer,SNAPS Breast Cancer Patient Study Breast Cancer Patients,Suspended,Observational,Case-Control,,Probability Sample,No,No
ZCHBC022,Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
R.18.02.34.R1.R2,Association of Hepatitis C Virus With Breast Cancer,Completed,Observational,Case-Control,,Non-Probability Sample,No,No
112991,Hybrid PET/MR Imaging of Acute Cardiac Inflammation After Left-Sided Breast Cancer Radiotherapy,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
TET-21-001,Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants,Recruiting,Observational,Case-Control,,Probability Sample,No,No
3055,Correlation of Predictive Accuracy of PREDICT Version 2.2 of Indian Women With Operable Breast Cancer,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
Breast Cancer Risk,Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
VGHKS18-CT11-17,CEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective Study,Completed,Observational,Cohort,,Non-Probability Sample,No,No
832165,Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT,Recruiting,Observational,Case-Only,,Non-Probability Sample,Yes,No
ICO-2019-08,Interest of Touch-massage in Hospital Day Care,Completed,Observational,Cohort,,Non-Probability Sample,No,No
biomarkers in breast cancer,Circular RNA and Chemerin in Breast Cancer Patient,Not yet recruiting,Observational,Case-Control,,Probability Sample,No,No
GEICAM/2017-07,Registry Study of Pregnancy and Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
LCCC2207,"Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians",Recruiting,Observational,Ecologic or Community,,Non-Probability Sample,No,No
MCC-21448,Study of Screening Brain MRIs in Stage IV Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2017-0588,Implementation of a Web-based Decision Aid for Breast Cancer Surgery,Completed,Observational,Cohort,,Non-Probability Sample,No,No
UPCC 19121,Role of the Immune Environment in Response to Therapy in Breast Cancer,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
21-480,A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
LQ005,Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer,Unknown status,Observational,Cohort,,Probability Sample,Yes,No
2021LC2210,Remote Breast Cancer Screening Study,Recruiting,Observational,Case-Only,,Probability Sample,No,No
17-581,Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds,Completed,Observational,Other,,Probability Sample,No,No
NCC3299,Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology,Recruiting,Observational,Other,,Non-Probability Sample,No,No
ESR-21-21505,The Treatment Situation of Chinese County Population With Breast Cancer,Recruiting,Observational,Other,,Probability Sample,No,No
LUMHS/REC/-17,Association of Tumour Grade and Sex Steroid Receptor as a Prognostic Index in Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
2014P002688a,Promoting Earlier Detection of Breast Cancer in Rwanda: Scaleup in the National Health Care System,Completed,Observational,Cohort,,Non-Probability Sample,No,No
ODELIA,A Retrospective Analysis of Magnetic Resonance Imaging Data for Breast Cancer Screening in the Open Consortium for Decentralized Medical Artificial Intelligence,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
2018-TJ-BCP,SEMA4C as a Relapse Biomarker in Breast Cancer,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
2017-03-002A,PET/MR Radiomics for Breast Cancer Diagnosis,Recruiting,Observational,Cohort,40 Weeks,Non-Probability Sample,No,No
1905795920,Breast Cancer Self-Efficacy Scale for Partners,Terminated,Observational,Cohort,,Non-Probability Sample,No,No
4-2018-0254,Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CDK-HeCOG-2019,Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy,Completed,Observational,Cohort,,Non-Probability Sample,No,No
2020-0327,Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
SH ABCD,Autoantibodies in Breast Cancer Detection,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
1905202-3,ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies,Recruiting,Observational,Case-Only,,Probability Sample,No,No
2022-8048-23560,Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
GFY202001,Study of Prediction of Ovarian Reserve in Yong Breast Cancer Patients Treated With Chemotherapy,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2019-A01861-56,Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
18-634,Elevate! : An Elderly Breast Cancer Cohort Study,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
20 KHCC 202,Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
IRB # 21-0026,Tear Based Sample Collection Breast Cancer Detection,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
IRB00002991,Implementation of Online Adaptive Radiotherapy for Breast Cancer Patients on Ethos (BREAST-ART),Recruiting,Observational,Cohort,,Probability Sample,No,No
LCCC 1954,Patient-centered Communication About Healthy Weight in Early Breast Cancer,Completed,Observational,Cohort,,Probability Sample,No,No
ESR-17-12934,Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer,Unknown status,Observational,Case-Control,,Probability Sample,No,No
69HCL22_0613,Effect of Physical Activity in Patients With Breast Cancer.,Withdrawn,Observational,Cohort,,Non-Probability Sample,No,No
LCCC2213,Metastatic Breast Cancer-Specific Prognostic Tool,Recruiting,Observational,Ecologic or Community,,Non-Probability Sample,No,No
FMASUMD232/2021,Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Breast immune checkpoint,Relationship Between Breast Cancer Subtypes and Immune Checkpoints,Completed,Observational,Case-Control,2 Weeks,Non-Probability Sample,No,No
CentroHLO_EFBreastCancer,Evaluating and Following Breast Cancer Patients in a Better Way,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
elastography in breast cancer,Shear Wave Elastography Assessment of Neoadjuvant Chemotherapy Response in Patients With Invasive Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2018-177-IMP-EXP-4,Tumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast Cancer,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
PROICM 2020-01 OST,Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer,Completed,Observational,Cohort,,Probability Sample,No,No
18-281,Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer,Recruiting,Observational,Other,,Probability Sample,No,No
2021-A02676-35,Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment,Recruiting,Observational,Cohort,,Probability Sample,No,No
84434789,Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials,Not yet recruiting,Observational,Case-Crossover,,Probability Sample,No,No
2021-004,Acute Effects of Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: the PROTECT-06 Study,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CBS-PIK3CA,Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC,"Active, not recruiting",Observational,Other,,Probability Sample,No,No
ARNA Breast 2021,"In Vitro Study of the Liquid Biopsy Test System of the Diagnostic Value, in Women With Various Forms of Breast Cancer",Unknown status,Observational,Case-Control,,Probability Sample,No,No
SNP-17-001,Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer,Completed,Observational,Cohort,,Probability Sample,No,No
69HCL18_0769,Awareness About Breast Cancer Screening,Completed,Observational,Ecologic or Community,,Non-Probability Sample,No,No
2394,Predictive Model of Axillary Nodal Status After Neoadjuvant Chemotherapy in Breast Cancer Patients,"Active, not recruiting",Observational,Cohort,,Probability Sample,No,No
18-461,Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment,"Active, not recruiting",Observational,Case-Only,,Non-Probability Sample,No,No
2020-KY-064,Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
3049,Evaluating Breast Cancer Patients Modesty During Radiotherapy. A Multicentric Study,Completed,Observational,Cohort,,Non-Probability Sample,No,No
82944089,Discovering Factors in Metastatic Breast Cancer Patients Clinical Trial Experiences,Not yet recruiting,Observational,Case-Crossover,,Probability Sample,No,No
NewGiza University Protocol 1,The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study,Not yet recruiting,Observational,Case-Control,,Non-Probability Sample,Yes,No
3/19,Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
19-003085,"GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance",Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
Protocol EMIT-1,Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
17/09/621_Myosin VI,Nuclear Myosin VI - a Therapeutic Target in Breast Cancer,Unknown status,Observational,Other,,Non-Probability Sample,No,No
2017/1356,Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
IC 2016-07,"FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France",Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
left breast cancer,Cardiac Toxicity of Hypo Fractionated Radiotherapy in Left Breast Cancer,Not yet recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
180212-1,IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
CTRP6 in Breast Cancer,The Role of C1q Tumor Necrosis Factor-related Protein 6 in Breast Cancer,Unknown status,Observational,Case-Control,,Probability Sample,No,No
CESM in breast cancer,Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
SOLTI-1903,Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer,"Active, not recruiting",Observational,Other,,Probability Sample,No,No
Vitamin D in breast cancer,Prognostic Value of Vitamin D Levels in Egyptian Females With Breast Cancer,Unknown status,Observational,Case-Only,,Non-Probability Sample,No,No
19HLSEIN02,Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC,Completed,Observational,Cohort,,Probability Sample,No,No
KY20192114-C-1,Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study),Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
2019.089,Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment,Recruiting,Observational,Case-Only,4 Years,Probability Sample,No,No
Xist,XIST Gene Deletion in Breast Cancer Therapy,Unknown status,Observational,Case-Control,,Probability Sample,No,No
HERMIONE 13,Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
STANDPOINT,Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer,Recruiting,Observational,Case-Only,,Probability Sample,No,No
NL75855.091.21,Evaluation of Contrast Enhanced Breast CT for Diagnosis and Staging of Breast Cancer,Not yet recruiting,Observational,Cohort,,Probability Sample,No,Yes
CASE5118,Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
HR-HER2-RWS-01,The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
01-BR-003,Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
21-528,Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
DS8201-0002-EAP-MA,EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
2020-12/898,Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery,Completed,Observational,Cohort,,Probability Sample,No,No
CHUBX 2016/19,Adaptation of a Knowledges Exchange Portal Between (KEP) Healers and Patients : Obstacles and Sources to KEP Use for Breast Cancer Women,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
PI-0538-2017,Breast Cancer and Its Relationship With the Microbiota,"Active, not recruiting",Observational,Case-Control,,Probability Sample,No,No
21/4657,Health Technologies Readiness in Breast Cancer Patients,Completed,Observational,Cohort,,Non-Probability Sample,No,No
06-2020,Prevalence of Depression and Anxiety Among Breast Cancer Patients,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
CHIR-07-Sentimag,Magseed and Magtrace Localization for Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2020-0724,"Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study",Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
17-PP-19,Peri-gravidic Exposure to Endocrine Disrupting Persistent Organic Pollutants,Recruiting,Observational,Case-Control,,Probability Sample,No,No
PUMCH-BREAST-ctDNA screening,Clinical Application of ctDNA in Early Screening of Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
MD 177/2021,Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,,
A5481177,A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data Setting,Recruiting,Observational,Cohort,,Non-Probability Sample,,
2017-KY-19,The Establishment of a Survival Prediction Model for ER Positive / HER-2 Negative Advanced Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
Radiotherapy in breast cancer,Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study).,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
19-001004,Brain Health in Breast Cancer Survivors,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
19049,Specialist Recommendation on FBC (Familial Breast Cancer) Chemoprevention Prescribing,Completed,Observational,Other,,Probability Sample,No,No
Z211100002921033,The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CFDAIIUASABFDOBC,Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast Cancer,Unknown status,Observational,Other,,Non-Probability Sample,No,No
Breast cancer neoadjuvant,Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant Therapy,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2020-KY-063,Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer,Unknown status,Observational,Cohort,,Probability Sample,No,No
PUMCH-BC502,Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
SYSEC-KY-2018-018,Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
19-045,A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
PROICM 2019-16-BCU,Evaluation of Sexual Quality of Life for Breast Cancer,Completed,Observational,Other,,Probability Sample,No,No
ISTMET-BHWGI2022-1,Preoperative Radiotherapy and Systemic Therapy Following Surgery in de Novo Metastatic Breast Cancer,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
Cpetptmrbc,Correlation Between PET/CT Parameters and Tumor Markers in Recurrent Breast Cancer,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
4817,Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
EEBC,Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
symptom of breast cancer,Trajectory Analysis of Symptom Distress and Cancer-related Fatigue After Adjuvant Chemotherapy in Breast Cancer Female,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
IEO 0761/,Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
CARMA-2101,Cohort Study to Determine the Antitumor Activity of New CAR-macrophages in Breast Cancer Patients Derived Organoids,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
RWD_abemaciclib,Real-world Data in Patients With Breast Cancer Treated With Abemaciclib,Recruiting,Observational,Cohort,30 Months,Non-Probability Sample,No,No
Tiresias,To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer,Recruiting,Observational,Cohort,5 Years,Probability Sample,No,No
A5481125,Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.,Completed,Observational,Cohort,,Non-Probability Sample,,
20-1789.cc,Sexual Health in Breast Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
ML40952,Tw HER2 Positive Breast Cancer Productivity & Utility Study,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
19-003028,Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,Yes
V2_16-04-2020,Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy,Recruiting,Observational,Cohort,,Probability Sample,No,No
2022106,Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
17/0765,Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
1186,The Role of Genetic Factors in the Development of Breast Cancer in the Kazakh Population,Completed,Observational,Cohort,,Probability Sample,No,No
01-2021,"Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.",Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
D9673R00011,Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
APHP211593,Molecular Signature for Breast Cancer,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
FLA 18-057,Effects of Bariatric Surgery on Breast Density Improvement and Impact on Breast Cancer Risk in Severe Obese Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
HERdi PREDICT,A Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted Therapies,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
IAyas2,The Validity and Reliability of FIT-HaNSA in Breast Cancer Patients,Unknown status,Observational,Case-Control,,Non-Probability Sample,No,No
A5481176,A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark,Completed,Observational,Cohort,,Non-Probability Sample,,
20210312,Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer,Unknown status,Observational,Cohort,,Probability Sample,No,No
Sentinel lymph node biopsy,Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
SOC.04/20-21,Breast Screening Atypia and Subsequent Development of Cancer in England,Enrolling by invitation,Observational,Cohort,,Probability Sample,No,No
oddie2,Artificial Intelligence for breaST canceR scrEening in mAMmography (AI-STREAM),Recruiting,Observational,Cohort,,Probability Sample,No,No
FMASU R61/2020,Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
18-109,A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors,Recruiting,Observational,Cohort,,Probability Sample,No,No
BRAR1,of Androgen Receptor Expression in Breast Cancer With or Without BRCA Mutation,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
IRB16-0396,"Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Emotional security&mastectomy,Emotional Security and Quality of Life Among Breast Cancer Patient Who Have Undergo Mastectomy,Unknown status,Observational,Case-Only,,Non-Probability Sample,No,No
A5481115,Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan,Recruiting,Observational,Cohort,,Non-Probability Sample,,
Breast Audit,The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study,Completed,Observational,Other,,Non-Probability Sample,No,No
MRI in breast cancer,Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
20210601,Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study,Recruiting,Observational,Cohort,3 Years,Non-Probability Sample,No,No
IRB-2022-166,"Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study",Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
2490,Characterization of Extracellular Vesicles in Breast Cancer Patients,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
Cardiac safety study,Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
69HCL18_0310,Descriptive Observational Study of the Evolution of the Lifestyle Alteration in Patients With Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
2004-261-112,Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer,Terminated,Observational,Cohort,2 Years,Non-Probability Sample,No,No
APHP190505,Circulating Fetal Cells and Breast Cancer,"Active, not recruiting",Observational,Case-Control,,Probability Sample,No,No
22-280,Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
BakircayU,Factors Affecting Functionality in Breast Cancer Survivors,Completed,Observational,Cohort,,Non-Probability Sample,No,No
SGK-SFC-001,Susan G. Komens ShareForCures,Enrolling by invitation,Observational,Other,10 Years,Non-Probability Sample,No,No
MO39485,"A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America","Active, not recruiting",Observational,Cohort,,Probability Sample,,
SOC.03/20-21,"English Mammography Screening Outcomes by Age, Frequency and Test Threshold",Enrolling by invitation,Observational,Cohort,,Probability Sample,No,No
M2020 UK01,Breath Test to Predict Breast Cancer and Outcome of Mammography,Unknown status,Observational,Other,,Probability Sample,No,No
TRA05-GEFPICS,Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
BCP28,CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC,Recruiting,Observational,Cohort,,Probability Sample,No,No
LY2022-028-B,Pre-operative Therapy in Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
ATADEK-2021/14/16,Breast Cancer and Kinesiophobia and Physical Activity,Completed,Observational,Case-Control,,Probability Sample,No,No
2018-9567,Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Patients With ER+/HER2- Metastatic Breast Cancer,Recruiting,Observational,Other,,Non-Probability Sample,No,No
MD.21.09.521.R,The Significance of Radiologically Detected Intramammary Lymph Nodes in Prediction of Axillary Lymph Nodes Status in Breast Cancer Patients,"Active, not recruiting",Observational,Other,6 Months,Probability Sample,No,No
FISH in breast cancer,Partial PTEN Deletion in Breast Cancer,Not yet recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
CSPC-DMS-BC-13,Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.,Completed,Observational,Case-Control,,Non-Probability Sample,No,No
201819010.4,Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients,Unknown status,Observational,Cohort,,Non-Probability Sample,Yes,No
2018NTLS176,Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
18ON009,Developing a Diagnostic Tool to Predict Response to Chemotherapy,Unknown status,Observational,Cohort,,Probability Sample,No,No
21-3576.cc,Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
PANONC-1 Version: 1.1,Neoadjuvant Treatment of Breast Cancer,Not yet recruiting,Observational,Cohort,10 Years,Non-Probability Sample,Yes,No
AB-MR for Second Breast Cancer,Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
2019/FO244363,Long-term Effects of Breast Cancer Treatment,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
KYJJ-2021-186,Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,Yes
18-058,"Exercise, Fitness and Tumor Profiling in Breast Cancer Patients","Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
BCSCO003,Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
DSCN-EHT-NIS-BC001,A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
GEICAM/2016-03,Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Breast Screening with DWI,Breast Cancer Screening With Diffusion-weighted MRI in Women at High Risk for Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
21-183,"Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
ICO-2019-03,Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple Negatives,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
Soh-Med-23-01-07,Prognostic Value of Some Biochemical Markers in Breast Cancer,Not yet recruiting,Observational,Case-Only,,Probability Sample,No,No
Breast Cancer Screening,Diffusion-Weighted MRI for Breast Cancer Screening in Women With a Personal History of Breast Cancer,Not yet recruiting,Observational,Cohort,1 Year,Non-Probability Sample,No,No
A5481144,HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes,Terminated,Observational,Cohort,,Non-Probability Sample,,
D133FR00138,ALEXANDRIA Study Egypt,Completed,Observational,Other,18 Months,Non-Probability Sample,,No
grid.412416.4,The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer,Completed,Observational,Other,,Probability Sample,No,No
intestinal flora study,A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
ML42450,"Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey",Completed,Observational,Cohort,,Probability Sample,No,No
2018-09-007A,Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools,Recruiting,Observational,Cohort,,Probability Sample,No,No
Microbiome_BC&PnC,Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
R148/2021,TIL Relation to pCR After Neoadjuvant Therapy in Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
42127,Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
NACAGEP,"Gene Expression Profiling to Help Define the Need for Neo-Adjuvant Chemotherapy in HR+, HER- Breast Cancer Patients",Recruiting,Observational,Other,,Non-Probability Sample,No,No
2017MayPR898,A Communication Skills Package to Prevent Fear of Cancer Recurrence,Unknown status,Observational,Cohort,,Probability Sample,No,No
NCC 2019-0098,Life Style Modification for Breast Canccer Survivors Using Mobile App-based Human Coaching Program,Completed,Observational,Case-Only,,Probability Sample,No,No
A5481155,"Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy",Completed,Observational,Cohort,,Non-Probability Sample,,
APHP191059,BIOPSY SCANNER LLTECH© Technology for Diagnosis of Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
PUMCH-MUSD,A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early Diagnosis,Recruiting,Observational,Cohort,,Probability Sample,No,No
2020-08-06R,Early Detection of CMP in Patients With Breast Cancer Using Cardiac Magnetic Resonance,Recruiting,Observational,Cohort,,Probability Sample,No,No
COV-19 BUMDC,COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer,Completed,Observational,Case-Only,18 Months,Non-Probability Sample,No,No
2020-A01423-36,Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
C3441055,Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m,Completed,Observational,Cohort,,Non-Probability Sample,Yes,No
CRF-NHI01,Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PRO00034502,Tell us Your Food Story,Withdrawn,Observational,Case-Crossover,,Non-Probability Sample,No,No
Breast cancer in females,Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
E19137,Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile,Suspended,Observational,Case-Control,,Non-Probability Sample,No,No
CTO-IUSCCC-0803,Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis,Recruiting,Observational,Case-Only,,Probability Sample,No,No
18-010602,Screening CEDM in Intermediate and High-Risk Patient Populations,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
PROICM 2018-05 BCU,Sexual Quality of Life in Women During the First Year of Adjuvant Hormonal Treatment for Breast Cancer.,Completed,Observational,Other,,Probability Sample,No,No
CAAE: 91570318.5.0000.5149,Nutritional Status and Pharmacological Treatment: Impact on the Toxicity and Quality of Life of Patients With Colorectal and Breast Cancer,Unknown status,Observational,Cohort,,Probability Sample,No,No
SYSKY-2022-030-01,Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
KY20182079-F-1,Breast Cancer Treatment Based on Organ-like Culture,Unknown status,Observational,Case-Only,,Probability Sample,Yes,No
Radiation in breast cancer,Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
4-2018-0160,Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
ID4060,Atezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
0023041/i,MONOCENTRIC PERSPECTIVE STUDY: USE OF LIQUID BIOPSY WITH DIAGNOSTIC IMAGING,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2020_61,Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital.,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Shengjing-LJY04,Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
GEICAM/2017-04,Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA),Completed,Observational,Case-Only,,Probability Sample,No,No
BREAST,BRaziLian outcomE for metAStatic breasT Cancer,Recruiting,Observational,Cohort,2 Years,Non-Probability Sample,No,No
1808-42,Survey Study: Financial Impact of Breast Cancer Treatment,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
21-271,Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity,Recruiting,Observational,Cohort,,Non-Probability Sample,No,Yes
STUDY2019000317,Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
FirstHCMU_CB_001,Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast,Unknown status,Observational,Other,,Probability Sample,No,No
A5481178,A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,,
dAGEs,"Dietary Advanced Glycation End Products, Inflammation and Oxidative Stress in Breast Cancer Patients",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
NIR-THERMA-02,A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers,Completed,Observational,Cohort,,Non-Probability Sample,No,No
E7389-M082-602,A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants,Completed,Observational,Cohort,,Probability Sample,No,No
STUDY00001233,Novel Thermal Imaging Technique for Breast Screening,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
INCASE0518,Artificial Intelligence vs Physicians for Breast Cancer Patients Information,Completed,Observational,Cohort,,Non-Probability Sample,No,No
INST 1607,Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Yunwei Wei 2019-09-13,Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy,Unknown status,Observational,Case-Control,,Probability Sample,Yes,No
6788,Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
NCC1824,Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
NCC1867,The Psychology of Chinese Breast Cancer Patients,Enrolling by invitation,Observational,Other,,Non-Probability Sample,No,No
2-102-21,Towards Early Detection of Breast Cancer in High Risk Population,Not yet recruiting,Observational,Case-Control,,Probability Sample,No,No
HunanCH-BC-001,Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer,Not yet recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
Neveen,"Demographic , Clinicopathological Characteristics and Survival of Breast Cancer",Not yet recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
Melody_002,"Melody®, a Lab Developed Test for Breast Cancer for Women With Dense Breast Tissue",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Shengjing_001,Study on Bisphosphonates Targeting Triple-negative Breast Cancer,Recruiting,Observational,Case-Only,,Probability Sample,No,No
PUMCH-BC501,Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PCS-001,Breast Cancer Liquid Biopsy Trial,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
C3441053,Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,Yes,No
YOUNGBC-7,18F-FES PET/CTs Additional Clinical Value in ER+ BC,Completed,Observational,Cohort,,Non-Probability Sample,No,No
LUN_MMG_121,Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer,Completed,Observational,Cohort,,Probability Sample,No,Yes
LCCC2105,Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
RJrapidplan,RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2-049-18,Randomised Controlled Study of Physical Exercise Intervention in Breast Cancer Patients at Risk of Anthracycline-induced Cardiomyopathy: The EMBRACE Study,Recruiting,Observational,Case-Control,,Probability Sample,No,No
MIES-BCNAT,Multimodal Imaging Evaluation System of Axillary Lymph Node Staging and Treatment Strategy for Breast Cancer Neoadjuvant Therapy,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
MACSSI (ET18-150),MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire),Recruiting,Observational,Cohort,,Non-Probability Sample,,
NCC2019-0142,Prospective Cohort Study of Breast Cancer Patients Treated With Radiotherapy,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
NIS12501,"A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
20210504,MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
18-2444.cc,Facial Skin Health Tracking Feasibility in Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
OkanU2,Influence of Multidisciplinary Breast Tumor Board on Physician Decision,Unknown status,Observational,Other,2 Years,Non-Probability Sample,No,No
TRICIA,TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence,Recruiting,Observational,Cohort,,Probability Sample,No,No
19-003532,Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers in Patients Undergoing Regional Nodal Irradiation for Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
PALBOCOMP,Analysis of Palbociclib Treatment in Patients With Advanced Breast Cancer Within a Compassionate Use Programe,Completed,Observational,Cohort,,Non-Probability Sample,No,No
LACOG 0221,"Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
1780,Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
YANWQ002,the New Geneswell BCT in Vitro Diagnosis of Breast Cancer Prognosis,Unknown status,Observational,Cohort,,Probability Sample,No,Yes
MR-01,Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PALBOSPAIN,Observational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
99mTc-ADAPT6,99mTc-ADAPT6-based HER2 Imaging in Breast Cancer,Completed,Observational,Cohort,,Probability Sample,No,No
9745,CESM ABMR Breast Cancer Screening Trial,Completed,Observational,Case-Crossover,,Non-Probability Sample,No,Yes
STUDY00022698,MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals,Recruiting,Observational,Other,,Non-Probability Sample,No,
CLEE011AUS64,A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors,Completed,Observational,Cohort,,Probability Sample,No,No
SCAN-B-rec,Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec),Recruiting,Observational,Cohort,10 Years,Non-Probability Sample,No,No
SLNB-ACP,Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents,Enrolling by invitation,Observational,Cohort,6 Years,Non-Probability Sample,,
AI-BMRI,Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk Women,Recruiting,Observational,Cohort,,Probability Sample,No,No
OMICS Mark,Metabolomics Explores Biomarkers for Metastatic Breast Cancer,Unknown status,Observational,Case-Control,5 Years,Non-Probability Sample,No,No
SMC 2018-07-014-011,Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device,Unknown status,Observational,Case-Only,12 Months,Non-Probability Sample,No,No
2022-017,Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
GEICAM/2018-03,Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer,Recruiting,Observational,Cohort,10 Years,Non-Probability Sample,No,No
BC-P31,Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
EORTC-1550-BCG,Dissecting the Pathways of Therapy Resistance in Early Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
handan1,Circulating Tumor Cells Screen for Breast Cancer,"Active, not recruiting",Observational,Case-Control,3 Years,Probability Sample,No,No
IOM-120465,Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
2-025-19,Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?,Unknown status,Observational,Case-Control,,Probability Sample,No,No
D9673R00025,A Study of Patients Receiving T-DXd (Trastuzumab Deruxtecan) for Treatment of HER2+ Unresectable and/or Metastatic Breast Cancer,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
R868/18-IEO 916,Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
309424,Breast CANcer Risk Assessment in Younger Women: BCAN-RAY,Not yet recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
Melody_001,"Validation of Melody®, a Tear-based Screening Assay for Breast Cancer",Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
19-1812.cc,"Fertility Changes Due to Cancer: an Investigation of Meaning, Psychological Distress, and Psychologi","Active, not recruiting",Observational,Cohort,,Probability Sample,No,No
I3Y-NS-O003,Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients With Symp-tomatic Visceral Metastases or High Tumor Burden,Recruiting,Observational,Case-Only,,Probability Sample,No,No
RG_16-108,NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
2021C0128,"Brain Imaging, Nutrition, and Cognition in Breast Cancer Survivors",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
20_RIPH3_06,Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique,Recruiting,Observational,Cohort,,Probability Sample,No,No
FAST-F-PG01,Ultra-hypofractionated Radiotherapy in Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
20-001670,Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
NCCH2113,Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study,Recruiting,Observational,Cohort,3 Years,Probability Sample,No,No
YU-FTR-ST-01,"The Effects of Upper Extremity Lymphedema on Posture, Upper Extremity Functions, and Quality of Life",Completed,Observational,Case-Only,,Non-Probability Sample,,
Soh-Med-23-01-34,EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast,Not yet recruiting,Observational,Other,,Probability Sample,No,No
HNCH-MBC09-BM03,Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
E19059,Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
NCT20210157-AI-ROL,Artificial Intelligence in Breast Cancer Screening in Region Östergötland Linkoping,Completed,Observational,Cohort,,Non-Probability Sample,No,No
D9673R00028,PROVIDENCE - Real-world Study in Patients With HER2-positive Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan and Offered PRO-React Onco,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,,
BC-Genetics,Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
2022-A02271-42,Cost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer.,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CNIL-2033408,Chronic Pain and Minor Breast Cancer Surgery,Completed,Observational,Cohort,,Non-Probability Sample,No,No
REG-028-2021,Multimodal Pain Treatment for Breast Cancer Surgery - a Prospective Cohort Study,Recruiting,Observational,Cohort,12 Months,Probability Sample,No,No
201801559A3,Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
CMTNCMB,Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test,Unknown status,Observational,Other,,Probability Sample,No,No
2022/0226,Risk Factors for Shoulder Joint Motion Restriction,Not yet recruiting,Observational,Case-Control,,Probability Sample,No,No
SYSUCC-011,Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer,Terminated,Observational,Cohort,,Probability Sample,No,No
20-1866.cc,Promoting Informed Choice for Breast Cancer Screening,Recruiting,Observational,Cohort,,Probability Sample,No,No
RS1637/21,Single-cell RNAseq Breast Cancer,Recruiting,Observational,Cohort,24 Months,Non-Probability Sample,No,No
S64752,Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer,Completed,Observational,Case-Control,,Probability Sample,No,No
CDR0000643461,Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.,Unknown status,Observational,Case-Only,,Non-Probability Sample,No,No
OSU-21065,Impact of Dietary Inflammatory Potential on Breast Cancer Risk,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
A5481167,Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea,"Active, not recruiting",Observational,Cohort,,Probability Sample,,
ENDO-RESIST,Determinants of Acquired Endocrine Resistance in Metastatic Breast Cancer: A Pilot Study,Recruiting,Observational,Cohort,,Probability Sample,No,No
21-325,Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
EORTC QLQ BR45,Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
1234,Monitoring of Chronic Conditions in Breast Cancer,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
BreastctDNA01,Breast Cancer Liquid Biopsy Stratification,"Active, not recruiting",Observational,Other,,Probability Sample,No,No
A5481145,"A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer",Completed,Observational,Case-Only,,Non-Probability Sample,,
Concordance,Concordance Between Liquid and Tissue Biopsy,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
UW16151,Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
6037248,Using a Blood Test to Monitor Metastatic Breast Cancer Treatment,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
TJ-IRB20211128,Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer,Recruiting,Observational,Case-Only,,Probability Sample,No,No
131916,Financial Toxicity in Breast Cancer Surgery,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
DRLCOLCT001,"Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-",Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
FNF201830,Health-promoting Lifestyle in a Genetic Counseling Clinic,Completed,Observational,Other,,Non-Probability Sample,No,No
Genetic study and TDM,Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
YDPLD191016-I1-SYSU-001,Biomarkers of Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients,Recruiting,Observational,Cohort,1 Week,Probability Sample,No,No
A5481136,Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region,Recruiting,Observational,Cohort,,Probability Sample,,
69HCL16_0536,Facilitate and Sustain Return to Work After Breast Cancer,Recruiting,Observational,Other,,Non-Probability Sample,No,No
IIT-0026,Prognostic Indicators for Radiation-induced Breast Fibrosis,Not yet recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
LCCC2241,Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
YLiu,Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
2018-A02191-54,Needs Assessment After Cancer in Patients Treated for Breast Cancer,Completed,Observational,Cohort,,Probability Sample,No,No
CLEE011ABR02,Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,,
D9673R00004,"Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status",Completed,Observational,Cohort,,Non-Probability Sample,No,No
SYSEC-KY-KS-2019-099,Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy,Completed,Observational,Cohort,,Non-Probability Sample,Yes,No
SYSEC-KY-KS-2019-055-001,MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
21-161,A Study of Attention and Memory Processes in Breast Cancer Survivors,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
ONC-010,EndoPredict® Extended Endocrine Trial (EXET),Terminated,Observational,Case-Only,6 Years,Non-Probability Sample,No,No
CLEE011AFR01,Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France,Recruiting,Observational,Cohort,,Non-Probability Sample,,
178-2018,Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy,Recruiting,Observational,Cohort,5 Years,Probability Sample,No,No
OMC2018/01,Implementing Patients´ Competence in Oral Breast Cancer Therapy,Unknown status,Observational,Cohort,,Non-Probability Sample,,
AB PoC 2021 RUS,Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
2019.444,Fibrotic Focus in Breast Cancer,Not yet recruiting,Observational,Case-Only,,Probability Sample,No,No
1107210020,Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer,Completed,Observational,Other,,Probability Sample,No,No
IRB00048455,Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CCR5654,"Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast Cancer",Enrolling by invitation,Observational,Other,,Non-Probability Sample,No,No
2022-YXZX-YX-08,Ultrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node Metastasis,Not yet recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
NCKUH SLNB,The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients,"Active, not recruiting",Observational,Case-Only,5 Years,Non-Probability Sample,No,No
LB1802,Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer,Recruiting,Observational,Case-Only,5 Years,Non-Probability Sample,No,No
Geneplus2020BC01,ctDNA Monitoring in Early Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
19-005860,Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
2020-010,Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
Contralateral Screening,Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2007-206-1145,"Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer",Not yet recruiting,Observational,Cohort,2 Years,Non-Probability Sample,No,No
2019.629,Artificial Intelligence in Mammography-Based Breast Cancer Screening,Recruiting,Observational,Cohort,,Probability Sample,No,No
EORTC-1617-QLG-BCG,Follow-up in Early and Locally Advanced Breast Cancer Patients,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-17,Real-world Study of UTD1 in Chinese Advanced Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Metastatic Breast Cancer,"Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer",Recruiting,Observational,Cohort,3 Years,Non-Probability Sample,No,No
KCSG BR19-15,T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer,Unknown status,Observational,Case-Only,,Non-Probability Sample,No,No
GE-280-401,Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
CER2021,"Prevalence of Lymphedema in Valle Del Cauca, Colombia.","Active, not recruiting",Observational,Cohort,,Probability Sample,No,No
MD 134/2022,Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
A5481093,A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib),Not yet recruiting,Observational,Case-Control,,Probability Sample,,
LUN_DBT_121,"Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT",Recruiting,Observational,Cohort,,Probability Sample,No,Yes
2019/00283,A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
GO 22/41,Reliability and Validity of The 6 Minute Pegboard and Ring Test in Patients With Breast Cancer,Completed,Observational,Other,,Probability Sample,No,No
07068-02,Oxygen Partial Pressure After Breast Cancer Surgery,Recruiting,Observational,Cohort,1 Day,Probability Sample,No,No
YOUNGBC-16,MammaPrint Value for Pre-menopausal Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
99mTc-DARPinG3 breast cancer,99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-24,Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-6,Real World Study of Lapatinib Among Metastatic Breast Cancer Patients,Completed,Observational,Cohort,,Non-Probability Sample,No,No
PI20/596,"Long-term Outcomes After Breast Cancer Liver Metastasis Surgery: an European, Retrospective, Snapshot Study",Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
SCBCG-022,A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
HERMIONE-10,Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
B00157,A Pilot Study of Ultrasound-guided Vacuum-assisted Excision of Breast Cancers,Completed,Observational,Cohort,,Probability Sample,No,No
A5481166,Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,,
D081CC00012,LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS),Recruiting,Observational,Cohort,,Non-Probability Sample,,
Luminal A sirt1,Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
DokuzEU.Com.Garments,COMPRESSION GARMENTS in BREAST CANCER-RELATED LYMPHEDEMA,Completed,Observational,Other,,Non-Probability Sample,No,No
MC200302,"Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study",Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
A5481154,Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
22-002857,"Assessment of the Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Systemic Therapy and Surgery, UTMOST Trial",Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,Yes
IFOM-CPO007/2019/PO006,A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer,Recruiting,Observational,Other,,Non-Probability Sample,No,No
S-detect 2019,Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer,Completed,Observational,Cohort,,Probability Sample,No,No
AABCSR,Stress Reactivity Among African American Breast Cancer Survivors,Completed,Observational,Cohort,,Non-Probability Sample,No,No
FMSU2017-002B,Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study,Completed,Observational,Case-Crossover,,Probability Sample,No,Yes
2022-0651,The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-10,Pyrotinib Plus Vinorelbine in HER2+ Metastatic Breast Cancer Patients,Completed,Observational,Cohort,,Non-Probability Sample,No,No
20-1434.cc,Cancer Patient Perspectives During COVID-19,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
CSPC-KAL-AE-01,Real-world Study for the Safety of Albumin-Bound Paclitaxel in Recurrent or Metastatic Breast Cancer,Unknown status,Observational,Other,,Non-Probability Sample,No,No
SCBCG-021,A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
CLIN-52014-452,Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment,Recruiting,Observational,Cohort,,Probability Sample,No,No
201805027RSA,East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction,Recruiting,Observational,Case-Only,,Probability Sample,No,No
KY2022-097-B,CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
Radiodermatitistalita60,The Use of Photobiomodulation in the Management of Radiodermatitis in Breast Cancer Patients,Not yet recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
MEDOPP367,Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status,Recruiting,Observational,Cohort,,Probability Sample,No,No
YXH2022ZX02167,Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy,Recruiting,Observational,Case-Control,,Non-Probability Sample,Yes,No
21-06023682,"De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PUMCH-BC500,Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer,Recruiting,Observational,Cohort,3 Months,Non-Probability Sample,No,No
S2020-300-01,Sonazoid Contrast-enhanced Ultrasound in Assessing Effectiveness of Neoadjuvant Chemotherapy in Breast Cancer Patients.,Unknown status,Observational,Other,,Probability Sample,No,No
99mTc-DARPinG3,99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy,Completed,Observational,Cohort,,Non-Probability Sample,No,No
Soh-Med-22-05-24,Dosimetric Comparison of Three Radiation Techniques for Hypofractionated Whole Breast Radiotherapy in Early Breast Cancer,Not yet recruiting,Observational,Other,,Probability Sample,No,No
SYSEC-KY-KS-2019-054-001,Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
RTM 2015,Microwave Radiometry for the Diagnosis and Monitoring of Breast Cancer,Withdrawn,Observational,Cohort,,Non-Probability Sample,No,No
Breast-Chi-2022,Outcome of Tucidinostat-Based Therapy in HR+ Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitor,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
38RC19.362,Feasibility Study on the Characterization of the Immune Profile of Young Patients After Treatment for Breast Cancer,Unknown status,Observational,Other,,Non-Probability Sample,No,No
CTFSp161,Personalised Disease Monitoring in Metastatic Breast Cancer,Recruiting,Observational,Other,,Non-Probability Sample,No,No
US-MAM,The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.,Recruiting,Observational,Cohort,,Probability Sample,No,Yes
P0268,Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients,Completed,Observational,Cohort,,Non-Probability Sample,No,No
PUMCH-BC503,Evaluation of Prognostic Monitoring for Young Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
TIPN in China,Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer,Unknown status,Observational,Case-Control,,Non-Probability Sample,No,No
ShandongCHI-08,Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients,Unknown status,Observational,Cohort,5 Years,Non-Probability Sample,No,No
AI-BMRI-S,Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast Cancer,Recruiting,Observational,Cohort,6 Months,Non-Probability Sample,No,No
JTU-6H-20211230001,Effect of the Axillary Lymphatic /Vein Reflux Ratio on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer,Recruiting,Observational,Cohort,1 Year,Probability Sample,No,No
SHEPHERD-2021-2,Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
A5481168,Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC,Recruiting,Observational,Cohort,,Non-Probability Sample,,
05022020,FALSE POSITIVE FINDINGS IN BREAST CANCER TOMOSYNTHESIS,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
2021C0102,"Remote Assessment of Cognition, Insulin Resistance and Omega-3 Fatty Acid Biomarkers in Breast Cancer Survivors",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CTO-IUSCCC-0758,Breast Cancer BRCA1 Carriers: a Pilot Study,Withdrawn,Observational,Case-Crossover,,Non-Probability Sample,Yes,No
SELEBREC,Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
NOGGO B3,Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer,"Active, not recruiting",Observational,Case-Only,10 Years,Non-Probability Sample,No,No
AI-Breast-US,"Using Deep Learning Methods to Analyze Automated Breast Ultrasound and Hand-held Ultrasound Images, to Establish a Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer.",Recruiting,Observational,Other,,Probability Sample,No,Yes
18-195,Screening For BCRL In Targeted Therapy For Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
2021-0532,Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy,Recruiting,Observational,Cohort,,Probability Sample,No,No
Version 1.0_16.08.2021,TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
82071993,Assessment of Brain Cognitive Impairment in Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
2019-A02397-50,Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein),Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
YBCSG-22-08,Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions,Completed,Observational,Cohort,,Probability Sample,No,No
RSINETE,RWS of Inetetamab HER2 Positive Advanced Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
18-240,"Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2022/0035983,The Unmet Needs and the Workplace Reintegration of Breast Cancer Patients: the NEW-BreCa Project,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
38406,Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery,Recruiting,Observational,Cohort,3 Months,Probability Sample,No,No
2020/134,Analgesic Efficacy of Erector Spinae Plane Block After Breast Cancer Surgery,Completed,Observational,Cohort,,Probability Sample,No,No
IEO 0834/,CDH1 Germline Mutations in Lobular Breast Cancer,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
D8664R00002,Zoladex® 10.8 BC RWS,Recruiting,Observational,Case-Control,,Probability Sample,No,No
CHD049-17,Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
270-2018,Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer,"Active, not recruiting",Observational,Cohort,,Probability Sample,No,No
soh-Med-21-10-17,Adjuvant Whole Breast Irradiation in Five Fractions Versus Fifteen Fractions in Early Breast Cancer,Recruiting,Observational,Case-Control,,Probability Sample,No,No
HR-BLTN-016,Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer,Recruiting,Observational,Cohort,2 Years,Non-Probability Sample,No,No
KSVGH20-CT7-26,Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution,Unknown status,Observational,Cohort,,Probability Sample,No,No
D9673R00005,Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer,Completed,Observational,Other,,Non-Probability Sample,No,No
FDRT-BC015,The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
REaCT-Algorithm,Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
A5481159,Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone,Completed,Observational,Cohort,,Probability Sample,,
SunYatsenU2H-LQ5,Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
2021-SR-592,Anlotinib Combined With Chemotherapy for the Treatment of HER2 Negative Advanced Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PR351/20,TAD After Chemotherapy in Locally Advanced Breast Cancer,Recruiting,Observational,Cohort,3 Years,Probability Sample,No,No
IEO 1730,LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
GIM23-POSTER,Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
15.03.2023,Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.,Completed,Observational,Cohort,,Probability Sample,Yes,No
0000012,"Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient",Unknown status,Observational,Cohort,,Non-Probability Sample,Yes,No
2017-A03413-50,Metastatic Breast Carcinoma and Women Sexual Quality of Life,Completed,Observational,Cohort,,Non-Probability Sample,No,No
2021-0491,Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
2021-A02007-34,"Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients With HER2+ Breast Cancer","Active, not recruiting",Observational,Cohort,2 Years,Probability Sample,No,No
GIM26-TRASTHER,Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy,Recruiting,Observational,Other,,Non-Probability Sample,No,No
NCR191600,Bisphenol and Phthalate Exposures in Triple Negative Breast Cancer,Withdrawn,Observational,Cohort,,Non-Probability Sample,No,No
214-2018,Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI,Completed,Observational,Cohort,5 Years,Probability Sample,No,No
BAC,Satisfaction Survey for the Outpatient Unit Dedicated to Post-cancer Treatment,Completed,Observational,Cohort,,Non-Probability Sample,No,No
A5481123,RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.,Completed,Observational,Cohort,,Non-Probability Sample,,
EH20-251,Advanced Diffusion Tensor MRI for Breast Cancer,Recruiting,Observational,Other,,Non-Probability Sample,No,Yes
A5481095,TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.,Completed,Observational,Cohort,,Non-Probability Sample,,
Bioscore in breast cancer,Prognostic Significance of Bioscore in Nonmetastatic Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
275142,An EORTC Study Updating the QLQ-BR23 to BR45,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2022-A01192-41,SexoMBC2 Non Interventional Study,Recruiting,Observational,Other,6 Months,Non-Probability Sample,No,No
Cardiotoxicity study,Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients,Unknown status,Observational,Case-Control,,Non-Probability Sample,No,No
KN026-205,Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
2021P002943,Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2022-09/2057,The Effect of Premedication on Postoperative Pain and Anxiety in Breast Cancer Surgery,Recruiting,Observational,Cohort,,Probability Sample,No,No
CBYL719CIN02,Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world,Recruiting,Observational,Cohort,,Non-Probability Sample,,
CBYL719C2404,"A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting",Recruiting,Observational,Cohort,,Non-Probability Sample,,
ZhejiangCH-0709,RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
EUBREAST 3,AXillary Surgery After NeoAdjuvant Treatment,Recruiting,Observational,Cohort,5 Years,Probability Sample,No,No
OSU-20380,Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
s61033,A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer,"Active, not recruiting",Observational,Cohort,,Probability Sample,Yes,No
18/0059,Health Status of Women With Breast Cancer,Unknown status,Observational,Other,,Non-Probability Sample,,
Shengjing-LJY03,CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
21/079,Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2018-1133,Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer,"Active, not recruiting",Observational,Case-Only,,Non-Probability Sample,No,No
R018-SABI-00193,Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa Rica,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
Geriatric-CDK4/6,Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?,Not yet recruiting,Observational,Cohort,6 Months,Non-Probability Sample,Yes,No
Regina Elena,Endometrial Changes in Breast Cancer Women.,"Active, not recruiting",Observational,Cohort,,Probability Sample,No,No
Pro00087654,Family History in a Singapore Oncology Population,Completed,Observational,Cohort,,Non-Probability Sample,No,No
IRMA,Impact of Recurrence Score on Adjuvant Treatment Decisions in Breast Cancer Patients,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2020-2-4023,Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
69HCL21_0145,Immediate Breast Reconstructions Increasing,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
UPCC 17119,Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Ancillary Study,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
XJTU1AF-CRF-2018-001,Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
I 571719,Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
1B-21-6,Breast Cancer Survivorship Biorepository,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
AssiutU AAHelmy,Multimodal Ultrasonographic Assessment of Ipsilateral Axillary Lymph Nodes in Patients With Breast Cancer: A STARD Study,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Pro00100408,Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Polarhis,Assessment of Lumpectomy Margins With the Histolog Scanner in Comparison With Intraoperative Imaging Techniques,Completed,Observational,Other,,Probability Sample,No,No
32158620.0.0000.0072,Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia,"Active, not recruiting",Observational,Cohort,1 Year,Probability Sample,No,No
LightCT-PKUPH,Light-CT in the Diagnosis of Breast Tumor and Lymph Node,Recruiting,Observational,Cohort,,Probability Sample,No,Yes
2018-09-20 Version 1.2,Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,Yes,No
events in breast cancer,Skeletal Events of Hormonal Treatment and Radiotherapy in Patient With Breast Cacer,Unknown status,Observational,Cohort,24 Months,Non-Probability Sample,No,No
ILLUMINE,Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
MC220902,Evaluation of Endocrine Therapy-Induced Alopecia Among Postmenopausal and Premenopausal Female Patients With Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
ShengjingH 3,"Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy",Recruiting,Observational,Cohort,10 Years,Probability Sample,No,No
20923,"Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand",Terminated,Observational,Cohort,,Non-Probability Sample,No,No
SUN-2252,Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients,Recruiting,Observational,Cohort,3 Years,Probability Sample,No,No
2021-0669,Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
A5481122,Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,Yes,No
1890-1-2019,Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy,Completed,Observational,Other,,Probability Sample,Yes,No
IEO 0837/,Patients Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
PHDW-006,Psychological Factors and Oncological Outcomes of Triple-negative Breast Cancer,Unknown status,Observational,Cohort,1 Day,Non-Probability Sample,No,No
AnhuiPH,A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2,Unknown status,Observational,Case-Only,,Non-Probability Sample,No,No
UPCC 11121,"Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
S-64813,"Clinical, Histological and In-depth Molecular Characterization as Well as Experimental Models of Liver Metastasis From Patients With Breast Cancer in Order to Identify New Potential Treatment Avenues.",Not yet recruiting,Observational,Case-Only,2 Years,Non-Probability Sample,No,No
2020-0831,Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response Assessment,Withdrawn,Observational,Cohort,,Non-Probability Sample,No,No
ASSOCIHER,Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy,Completed,Observational,Cohort,,Non-Probability Sample,No,No
VICC BRE 20104,Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
EPTTCSM (239BRC18.0129),Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
"CD133, Breast Cancer",CD133 Expression in Mammary Invasive Ductal Carcinoma,Recruiting,Observational,Other,,Non-Probability Sample,No,No
2021-40-2343,RWE About QOL and Compliance of Patients With OFS in China,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
69HCL19_0593,"PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life Association for the First Line Treatment of HER2-positive Metastatic Breast Cancer, an Observational Prospective Multicenter Study",Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
20160504,Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Patients,Completed,Observational,Cohort,,Probability Sample,No,No
2022/005-OST,Exploratory Evaluation of the Functional/Emotional Life Characteristics During the First Year of Ongoing Endocrine Adjuvant Treatment With Aromatase Inhibitors in Breast Cancer Patients With Reduced Bone Mineral Density,Recruiting,Observational,Cohort,1 Year,Non-Probability Sample,No,No
YWBC-001,"A Multicenter, Open and Observational Real World Study on the Prognosis and Treatment in Young Women With Breast Cancer",Recruiting,Observational,Case-Only,5 Years,Probability Sample,No,No
AURORA US,Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
18HH4880,D4 Choline Breast PET/CT,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
IC 2020-15,Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
PALBO01/2021,Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period,Recruiting,Observational,Other,,Probability Sample,Yes,No
CLEE011AUS65,Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors,Completed,Observational,Cohort,,Non-Probability Sample,No,No
IUSCC-0647,Effects of Aromatase Inhibitor Therapy on Muscle Function,Completed,Observational,Cohort,,Non-Probability Sample,No,No
SL-2020076,Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2022-A00171-42,Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
MIMIR-mTNBC,Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
LCCC1934,Reverse Axillary Mapping in Breast Radiation Treatment Planning,Withdrawn,Observational,Cohort,,Non-Probability Sample,No,No
2020-12518,Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
UKT HT03_1,Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
2018-01-054,Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy,"Active, not recruiting",Observational,Case-Only,5 Years,Non-Probability Sample,No,No
BRAVE,QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.,Enrolling by invitation,Observational,Other,,Non-Probability Sample,No,No
NL76792.091.21,DLSCT for Breast Cancer Detection in Women With Dense Breasts,Recruiting,Observational,Cohort,,Probability Sample,No,No
190025,Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
108818,Early Detection of Cardiac Damage With CMR in Women With Breast Cancer,Unknown status,Observational,Cohort,,Probability Sample,No,No
A5481151,Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor,Completed,Observational,Cohort,,Non-Probability Sample,,
D0819C00005,Lynparza Breast Cancer Clinical Experience Investigation,Completed,Observational,Cohort,,Non-Probability Sample,,
MC220303,Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
20-009279,Evaluating the Association Between Changes in the Gut Microbiome and Chemotherapy-Induced Nausea in Women Receiving Chemotherapy for Stage I-III Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
KKKR-Neulasta OS-01,An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®),Completed,Observational,Cohort,,Non-Probability Sample,No,No
LCCC1745,"ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer",Completed,Observational,Cohort,,Non-Probability Sample,No,Yes
Organoids Breast,Developing Breast (Cancer) Organoids,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PUMCH-2020-EBC,A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients,Not yet recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
CIH-TZS-20190912,Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China,Recruiting,Observational,Case-Control,,Non-Probability Sample,Yes,No
ExtremeHypofractionationBreast,Postoperative Radiation of Patients With Breast Cancer in Extreme Hypofractionation.,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
KutahyaMSUcancer,Clinical Classification of Pain in Breast Cancer Survivors,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
POLAR-01,Treatment With Pyrotinib-Based Therapy in Lapatinib Resistant HER2-Positive Metastatic Breast Cancer,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,Yes,No
NEO-R-IPC 2019-041,Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy,Recruiting,Observational,Cohort,,Probability Sample,No,No
09.2018.,Diagnostic Accuracy of Dermal Thickness in Lymphedema,Completed,Observational,Other,,Probability Sample,No,No
ZLiu,Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer,Unknown status,Observational,Cohort,,Probability Sample,No,No
THALIA-01,Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
C-MOT,Copenhagen Master Observational Trial,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
BC-P32,Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
19-0448,Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
SYSKY-2022-445-01,"Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study",Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CGAprediting,The Value of Geriatric Assessments in Older Patients With Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CH-BC-086,Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
IRB00154162,Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection,Recruiting,Observational,Case-Only,,Non-Probability Sample,Yes,No
2020KT151,Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
NCC3222,Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
22-10590-BO,Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
4-2017-1108,"Cosmetic Outcome, Patient-reported Outcomes, and Reconstruction-related Complications in Breast Cancer Women Treated With or Without Post-mastectomy Radiation Therapy",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
GATTUM -1,Gated Radiotherapy in Left Sided Breast Cancer Patients,Unknown status,Observational,Cohort,,Probability Sample,,
RI-002,Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring),Completed,Observational,Cohort,,Non-Probability Sample,No,No
RECHMPL20_0130,Contraception and Cervical and Breast Cancer Screening in Obese Versus Non-obese Women,Completed,Observational,Cohort,,Non-Probability Sample,No,No
CBYL719C2005,Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib,Recruiting,Observational,Other,,Non-Probability Sample,,
BCIG,Clinical Study of Imaging Genomics Based on Machine Learning for BCIG,Not yet recruiting,Observational,Cohort,5 Years,Probability Sample,No,No
Neo-RT,Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
69HCL21_0552,NEOZOL_Follow-up Study,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
SAHZhejiangU---Breast,Application of Radiomics in Breast Cancer,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
PEAR-TNBC_ Protocol_v2.0,Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
ML42876,The Efficacy and Safety of Neoadjuvant Trastuzumab Plus Taxane With and Without Pertuzumab Therapy,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
MHICC-2018-003,"Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
IRB00049171,Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
2022-0239,Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
R21052,Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO),Recruiting,Observational,Cohort,3 Years,Non-Probability Sample,No,No
Exactis-05,RWD Study in HER2+ mBC Patients in Third-Line Therapy,Completed,Observational,Cohort,,Non-Probability Sample,No,No
ERC/2018/06/01,Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
844978,Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts,Recruiting,Observational,Other,,Non-Probability Sample,No,No
S2020-300,Prospective Multicenter Study on Clinical Application of Sonazoid in Breast Tumor,Recruiting,Observational,Other,1 Month,Probability Sample,No,No
50619,Patient Outcomes From Second Film-readers and Test Threshold Relaxation in Breast Screening,Enrolling by invitation,Observational,Cohort,,Probability Sample,No,No
2019-1237,Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
ACT-MBC,ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC),Recruiting,Observational,Case-Only,,Probability Sample,No,Yes
LACOG 0122,Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
55457122.3.0000.5330,Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2020-A02045-34,The E-consult Application for Patients With Breast Cancer: Interest in Empathy and Empowerment of Patients.,Completed,Observational,Cohort,,Non-Probability Sample,No,No
SMC2018-09-029-003,The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
2019-1042,Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
ReMig,Rehabilitation on Equal Terms - The ReMig Study,Recruiting,Observational,Cohort,,Probability Sample,No,No
EVE-CWM-01,Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study,Completed,Observational,Case-Only,,Non-Probability Sample,,
SAFE-FORWARD,Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2018-8984,Low Energy Dissection Vs. Electrocautery in Lumpectomy Shaved Surgical Margins,Unknown status,Observational,Case-Only,,Probability Sample,No,Yes
230/HĐĐĐ-ĐHYD,2D Speckle-tracking Echocardiography in Chemotherapy-induced Cardiomyopathy With Cardiovascular Risk Factors,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
A5481152,First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.,Recruiting,Observational,Cohort,,Non-Probability Sample,,
ANG-002,Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System,Completed,Observational,Cohort,,Non-Probability Sample,No,Yes
38RC20.120,"Complications After Lumpectomy, Sentinel Node and Radiotherapy in Breast Cancer Patients and Physiotherapy Care",Completed,Observational,Case-Only,1 Day,Non-Probability Sample,No,No
D19160,Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging,Completed,Observational,Cohort,,Non-Probability Sample,No,No
IO Panel,Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer,Unknown status,Observational,Case-Control,,Probability Sample,No,No
PA18-1077,"Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
IRB00076577,Oral Aromatase Inhibitors Modify the Gut Microbiome,Recruiting,Observational,Cohort,,Probability Sample,No,No
KEK 2021-D0051,HER2-directed Biosimilar in Breast Cancer: Real World ePRO,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
RD19/125787,Guide for Prioritisation of Patients for Referral to Breast Clinics,Suspended,Observational,Cohort,,Probability Sample,No,No
YOUNGBC-12,Eribulin in mTNBC Patients,Completed,Observational,Cohort,,Non-Probability Sample,No,No
X9001194,UK Ibrance Patient Program (IPP) Study,Completed,Observational,Cohort,,Non-Probability Sample,,
EXERT-BC,"EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA",Recruiting,Observational,Other,3 Months,Non-Probability Sample,No,No
yifeng,Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
MEC-2021-0829,An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-23,The Rechallenge of ADCs in MBC Patients,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
NEODOC-2021668610-165,Evaluation of NeoNavia® Biopsy System in Axillary Lymph Nodes,Unknown status,Observational,Case-Only,,Non-Probability Sample,No,No
00055029,Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
TADANAC,Targeted Axillary Dissection After Neo-adjuvant Chemotherapy,Recruiting,Observational,Other,,Non-Probability Sample,No,No
PF008,Treatment Patterns of Neratinib in HER2+ EBC in China,Not yet recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2018-0477,Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
712,Effects of Interpectoral-Pectoserratus Plane Block After Breast Cancer Surgery,Not yet recruiting,Observational,Cohort,10 Days,Probability Sample,No,No
202301160RINA,Novel MRI Techniques on Evaluation of Lymphedema,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2001272738,Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women,Withdrawn,Observational,Cohort,,Non-Probability Sample,No,No
2019-06-027,Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation,Unknown status,Observational,Cohort,3 Years,Non-Probability Sample,No,No
MRI in response assesment,Functional MRI in Predicting Response to Chemotherapy,Recruiting,Observational,Other,,Non-Probability Sample,No,No
19-5080,Cardio-Oncology Rehabilitation Exercise,Recruiting,Observational,Cohort,,Probability Sample,No,No
H1901940,IORT-Breast at Medical Center Navicent Health,Recruiting,Observational,Cohort,10 Years,Non-Probability Sample,No,Yes
A5481150,Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CETC 002,Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
00031569,Photoacoustic Lymph Node Imaging,Suspended,Observational,Case-Only,,Non-Probability Sample,No,No
2022-001,Deformable Image Registration for Breast Adaptive Tomotherapy,Completed,Observational,Cohort,,Probability Sample,,
829400,Abbreviated Breast MRI After Cancer Treatment,"Active, not recruiting",Observational,Other,,Non-Probability Sample,No,No
R_ReLoCC,Registry of Local Recurrences After Breast-conserving Surgery,Not yet recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
HelouEl,Factor Influencing Breast Surgery Type Decision-Making,Completed,Observational,Cohort,1 Day,Non-Probability Sample,No,No
2018/827,Aspects of Breast-conserving Surgery,Completed,Observational,Cohort,,Non-Probability Sample,No,No
RWS-PEGCSF,Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-13,18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response,Completed,Observational,Cohort,,Non-Probability Sample,No,No
A5481170,European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
EUBREAST-4,MEthods for LOcalization of Different Types of Breast Lesions,Recruiting,Observational,Cohort,,Probability Sample,No,No
69HCL17_0480,Collaborative Self-Management Support in Chronic Conditions - Qualitative Study,Completed,Observational,Other,,Non-Probability Sample,No,No
A5481158,Swedish Ibrance Registries Insights (SIRI),Recruiting,Observational,Cohort,,Non-Probability Sample,,
EUBREAST-11R,International Prospective REgistry on Pre-pectorAl Breast REconstruction,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
WSG-NIS04 / PROOFS,PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS,Recruiting,Observational,Cohort,10 Years,Non-Probability Sample,No,No
SCHBCC-N023,Patient Report Outcome-Reconstruction and Oncoplastic Cohort,Recruiting,Observational,Cohort,24 Months,Non-Probability Sample,No,No
MC1937,Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2018-A03054-51,Loreline Study: Characterization of Long Responders Under Eribuline,Completed,Observational,Cohort,,Non-Probability Sample,No,No
2020-10/850,Correlation of Preoperative Anxiety With Early Postoperative Cognitive Dysfunction in Breast Cancer Patients,Completed,Observational,Other,8 Months,Probability Sample,No,No
IEO 0758/,Histology VABB-Histology Post Surgery Pilot Project (BETTY Trial),"Active, not recruiting",Observational,Case-Only,,Non-Probability Sample,No,No
GN19ON381,Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy,Recruiting,Observational,Case-Control,,Probability Sample,No,No
2021/03,A Deep Learning Method to Evaluate QT on Ribociclib,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CCR 5006,Exploring the Link Between Cancer Genetics and PPSP,Unknown status,Observational,Case-Control,,Probability Sample,No,No
ICO-N-2018-12,Intravenous Chemotherapy and Plant-based Dietary Supplements,Completed,Observational,Cohort,,Non-Probability Sample,No,No
20180349,Health Economy Register,Completed,Observational,Cohort,,Non-Probability Sample,,
H-18016600,Metabolic and Bone Changes After Adjuvant Cancer Treatments in Early Non-metastatic Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
NIS07075,Real-life Pan-HER-blockade With Neratinib,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2018-172,The Effects of Wheat Sprouts Supplements on the Key Health Indicators of the Patients With Breast Cancer After Chemotherapy,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
A211601,Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502,Terminated,Observational,Cohort,,Non-Probability Sample,No,No
22-4004,African Cancer Genome: GMD,Recruiting,Observational,Cohort,1 Year,Non-Probability Sample,No,No
AAAS3402,Glucose Monitoring During Chemotherapy,"Active, not recruiting",Observational,Cohort,,Probability Sample,No,No
HUM00208684,Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CADEX-0001,Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer,Suspended,Observational,Cohort,,Probability Sample,No,No
İboelif22,"The Relationships Between Physical Activity Level, Quality of Life and Cognitive Level in Breast Cancer Patients",Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
SMC 2021-05-045,SMC Radiation Oncology Breast Cancer Cohort Study,Recruiting,Observational,Cohort,2 Years,Non-Probability Sample,No,No
SamsunU,Combination of Serratus Anterior and Pectoral Nerve Blocks (PECS II) as Main Anesthetic Method in Breast Cancer Surgery,Recruiting,Observational,Cohort,1 Year,Probability Sample,No,No
ShandongCHI-18,Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS Cohort,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
110.01-2016-GES-0001,Automated Breast Ultrasound Case Collection Registry,Terminated,Observational,Cohort,30 Months,Non-Probability Sample,No,Yes
IRB00081356,Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer,Recruiting,Observational,Cohort,,Probability Sample,Yes,No
VIL-HEQ-17-014,Health and QoL in Oncological Patients: Management of Bone Pathology in Italian Citbl Population,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
DS_v01,A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations,Recruiting,Observational,Cohort,,Probability Sample,No,No
4-2020-1093,Radiotherapy for Thoracic and Breast Cancer and the Related Cardiotoxicity Following Treatment (RACCOON),Unknown status,Observational,Cohort,,Probability Sample,No,No
GBG 107,Long-term Safety and Efficacy of GBG Study Participants,Recruiting,Observational,Cohort,10 Years,Probability Sample,No,No
CE-MRI&CESM in breast lesions,CE-MRI&CESM in Solid Breast Lesions,Not yet recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2021-03165,Validation of Scales in Reconstructive Breast Surgery,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CP-13-001,MarginProbe 2.0 Data Collection Protocol,Recruiting,Observational,Case-Only,,Probability Sample,No,Yes
I3Y-MC-B009,A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast,Not yet recruiting,Observational,Other,104 Weeks,Non-Probability Sample,Yes,No
17/222,Under- and Overdiagnosis in BreastScreen Norway,Completed,Observational,Other,,Non-Probability Sample,No,No
A5481160,"Demographics, Characteristics, Treatment Patterns and Clinical Outcomes of Palbociclib Treated Patients in Israel",Completed,Observational,Cohort,,Non-Probability Sample,,
ICO-2019-16,Satisfaction and QUality of Life After Breast REconstruction,Completed,Observational,Cohort,,Non-Probability Sample,No,No
M21REO,"Association of Silicone Breast Implant Reconstruction and -Enlargement With Overall Wellbeing, Lymphoma and Auto-immune Disease",Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
22-001501,Characterization of TRPC6 to Predict and Prevent Chemotherapy Related Cardiac Toxicity and Heart Failure in Patients With Breast Cancer,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
ET19-283,Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PROICM 2018-09 BSA,Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity,Recruiting,Observational,Other,,Non-Probability Sample,No,No
2019-4432,Screening Contrast-enhanced Mammography,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
NCC2021-0335,Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant,Enrolling by invitation,Observational,Cohort,,Probability Sample,No,No
LET,Lymphedema Treatment Registry,Not yet recruiting,Observational,Cohort,2 Years,Non-Probability Sample,Yes,No
TNBC,Epidemiology of TNBC in Asyut Clinical Oncology Department,Not yet recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
2020-06245,Effects of Expectations and Body Image in Breast Reconstruction,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-20,Detection and Analysis of MBC With Heterogeneous ER Expression,Completed,Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-21,Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
A5481128,Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.,Completed,Observational,Cohort,,Non-Probability Sample,,
YOUNGBC-3,500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI,Completed,Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-14,Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine,Completed,Observational,Cohort,,Non-Probability Sample,No,No
YOUNGBC-25,Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary Tumor,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
E2018210,Effect of Radiation and Its Timing on Breast Reconstruction in Chinese Patients,Unknown status,Observational,Cohort,2 Years,Non-Probability Sample,No,No
ShandongCHI-14,Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
BreastIls-1605,Endogenous Mechanisms of Inactivation of the Endothelium Tumor,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
7964,Clinical Validation of an Artificial Intelligence Algorithm to Help Interpret Mammograms,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2005P002282,Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions,Completed,Observational,Cohort,,Non-Probability Sample,No,No
mastectomy coverage formula 20,New Formula to Predict the Need for Reconstructive Coverage Following Mastectomy,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
17-001546,Evaluating Mepitel in Post-mastectomy Patients and the Role of the Skin Microbiome in Radiation Dermatitis,Completed,Observational,Cohort,,Probability Sample,,
C3441038,Korea Post Marketing Surveillance (PMS) Study of Talzenna®,Not yet recruiting,Observational,Case-Only,,Non-Probability Sample,Yes,No
ICO-2021-36,Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
L424,Cancer Surveillance and Support,Recruiting,Observational,Other,,Non-Probability Sample,No,No
20CX6399,Histolog Comparison to Standard Histology,"Active, not recruiting",Observational,Other,,Non-Probability Sample,No,No
Patient reported outcome,Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
21-374,A Study of Tumor Imaging With Multispectral Optoacoustic Tomography,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
3212,"A Survey to Assess Knowledge, Attitudes & Practices in Surgeons With Regards to Breast Conservation Surgery & Mastectomy",Completed,Observational,Cohort,,Non-Probability Sample,No,No
2018-06,Early Detection of Imaging-derived Subclinical Cardiac Injuries,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
B7391012,A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer,Not yet recruiting,Observational,Case-Only,,Probability Sample,,
ONCO-FIRE,ONCOlogy-targeted NLP-powered Federated Hyper-archItecture and Data Sharing Framework for Health Data Reusability,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2021-01534,Effect of Breast Implants om Mammography Screening,"Active, not recruiting",Observational,Cohort,2 Years,Non-Probability Sample,No,No
PPMP_INO,Persistant Post-mastectomy Pain in Breast Cancer : Incidence and Risk Factors,Completed,Observational,Cohort,,Probability Sample,No,No
Xiangan Hospital of XMU,Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.,Recruiting,Observational,Other,,Non-Probability Sample,Yes,No
110.01-2018-GES-0001,Automated Breast Ultrasound as an Adjunct to Screening Digital Breast Tomosynthesis,Withdrawn,Observational,Cohort,,Non-Probability Sample,No,Yes
NURS-IIR-IUSCCC-0748,Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
1/2020,Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective,Completed,Observational,Cohort,5 Years,Non-Probability Sample,No,No
060021-HMO-CTIL,"Health Care Disparities in Culturally Diverse, Special Needs & Disadvantaged Populations - Bridging the Gap",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
MC210301,"Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Yunwei Wei 2019-09-12,Study on Skin Microbiome of HFS,Unknown status,Observational,Case-Control,,Probability Sample,Yes,No
K170702J,Follow-up of Elderly Patients in Ambulatory Surgery,Unknown status,Observational,Cohort,,Probability Sample,No,No
2019-01395CE3508,Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
1613494-3,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island,Unknown status,Observational,Ecologic or Community,,Non-Probability Sample,No,No
CHIR-05-IMTAD,Ideal Marker for Targeted Axillary Dissection,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
EAQ201,COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PANTHERA,Evaluation of the Subjectively Perceived Pelvic Floor Function in Patients With Gynecological Tumors and Breast Cancer Under Systemic Tumor Therapy Using a Validated Questionnaire,Recruiting,Observational,Case-Only,3 Years,Non-Probability Sample,No,No
BIOC-046,A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2017C0165,Cancer Activity and Lifestyle Measurement Study,"Active, not recruiting",Observational,Case-Only,,Non-Probability Sample,No,No
RFID,Breast Localization: RFID Tags vs Wire Localization,Recruiting,Observational,Case-Control,,Probability Sample,No,No
5505,PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
2016-051-000001- 1731,The Role of Circadian Rhythms in Cancer-Related Symptoms,Unknown status,Observational,Case-Control,,Non-Probability Sample,No,No
None yet,An Observational Prospective Cohort Study Using an Actigraphy Device.,Completed,Observational,Cohort,,Non-Probability Sample,No,No
Abbreviated Breast MRI,Abbreviated Breast MRI in Cancer Detection,Unknown status,Observational,Case-Crossover,,Probability Sample,No,No
2669,Prospective Observational Study for Breast Microcalcifications Classification With Artificial Intelligence Techniques,Recruiting,Observational,Cohort,,Probability Sample,No,No
MCC-20257,Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk,"Active, not recruiting",Observational,Case-Only,,Non-Probability Sample,No,No
9785,Non-contrast DWI for Supplemental Screening,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,Yes
1708018471,Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome,Completed,Observational,Other,,Non-Probability Sample,No,No
APBI Registry,Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT),Withdrawn,Observational,Cohort,,Non-Probability Sample,No,No
ABCB1 in Paclitaxel Neuropathy,ABCB1 SNPs as Predictors of PIPN,Completed,Observational,Cohort,,Non-Probability Sample,No,No
19-315,Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
SB-2101,Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy,Recruiting,Observational,Cohort,,Probability Sample,No,No
2017/2805,Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery,"Active, not recruiting",Observational,Other,,Non-Probability Sample,No,No
Breast MRI,Non-mass Enhancement in Breast MRI,Unknown status,Observational,Case-Only,,Non-Probability Sample,,
DOLPHIN,Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CLEE011ARU01,"A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia",Recruiting,Observational,Cohort,,Non-Probability Sample,,
FIS-APBI-2019-02,Accelerated Partial Irradiation of the Breast: New Altered Fractionation,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
17/0774,Extended Follow up of the TARGIT-A Trial,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
21-3100.cc,Second Opinions in Oncology,"Active, not recruiting",Observational,Cohort,,Probability Sample,No,No
2-028-22,Chemotherapy Induced Cognitive Impairment,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
3734,Assessment of the Breast Cosmesis Using Deep Neural Networks: an Exploratory Study (ABCD),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
6077,Multicentric Study for External Validation of a Deep Learning Model for Mammographic Breast Density Categorization,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
2022LS100,Assessing the Time Demands of Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
GS3,GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
QT MG PRE Phase 1,Understanding Patient Experience and Preferences for the QT Scanner Compared to Mammography,Suspended,Observational,Case-Only,,Non-Probability Sample,No,Yes
2018-A011828-47,Assessment of Health Related Quality of Life in Women Who Underwent Breast Reconstruction After Radical Surgery,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2020-0501,Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CBYL719CKR01,A Post Marketing Surveillance on Piqray in Korea,Recruiting,Observational,Cohort,,Non-Probability Sample,,
RECHMPL20_0005-UF7919,Hepatitis C Screening Paired With Mammography,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Telerehab CH Usability,Telerehabilitation Cognitive Impairments Following Chemotherapy Usability Study,Completed,Observational,Other,,Non-Probability Sample,No,No
ICO-N-2018-15,Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec),"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
2018-0345-1105,Feasibility of Preoperative Tattooing of Percutaneously Biopsied Axillary Lymph Node: A Quasi Experimental Pilot Study,Unknown status,Observational,Other,,Non-Probability Sample,No,No
RECHMPL21_0379,Cancer Predictive Score on Breast MRI,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
2022000438,Clinical Outcomes and Patient Satisfaction With Use of the Amma System,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,Yes
RS1307/20,Prognostic Relevance of Coagulation Activation in RIsk Assessment and Stratification,Recruiting,Observational,Cohort,24 Months,Non-Probability Sample,No,No
H-18041465,Pain Phenotyping of Patients With Bone Cancer Pain,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
18-294,"Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship","Active, not recruiting",Observational,Case-Control,,Non-Probability Sample,No,No
2020-0974,Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
HP-00088085,GammaPod Registry and Quality of Life Nomogram,Recruiting,Observational,Cohort,1 Year,Probability Sample,No,Yes
NL82061.096.22,Evaluating the Use of Magnetic Resonance Imaging and Contrast Enhanced Mammography After MagTrace® Use,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
MCC-20335,Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,Yes
NEUROTOX,Relationship Between Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy,Recruiting,Observational,Case-Only,,Probability Sample,Yes,No
ELEGANT - ET18-262,Satisfaction & Efficacy of Compression Using Surgical Gloves in Chemo-induced Peripheral Neuropathies,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
A5481065,Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®,Recruiting,Observational,Ecologic or Community,,Probability Sample,No,
HP-00068503,Cardiac MRI Biomarker Testing (GCC 1618),Terminated,Observational,Case-Control,,Probability Sample,No,No
NL72808.068.20,AFT: Introduction of a Full Breast Reconstructive Method,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
R17096,Intraoperative Tissue Identification by Analyzing Surgical Smoke,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
DMT-2015.002,Delphinus SoftVue™ ROC Reader Study,Completed,Observational,Case-Control,,Probability Sample,No,Yes
KY2019,Recurrence Risk Evaluation by 21-gene Detection,Completed,Observational,Cohort,,Probability Sample,No,No
S61864,Magnetic Seed Localisation for Nonpalpable Breast Lesions,Completed,Observational,Cohort,,Non-Probability Sample,No,Yes
IRAS 283017,Comparison of Patient Reported Outcome Measures Using the BREAST-Q Questionnaire in Patients Undergoing Pre Versus Sub-pectoral Implant Based Immediate Breast Reconstruction.,Unknown status,Observational,Cohort,,Probability Sample,No,No
20/WS/0110,Contrast-Free Magnetic Resonance Imaging for Breast Disease,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
LBS-CA-PTL-033,HydroMARK Post-market Clinical Follow-up Study,Recruiting,Observational,Other,6 Weeks,Non-Probability Sample,No,Yes
U21-08-4519,Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning,Recruiting,Observational,Case-Only,,Probability Sample,No,No
PB-2020-01,ARGONAUT: Stool and Blood Sample Bank for Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,Yes,No
2020_16,"Metabolism, Circadian Rhythms and Ovarian Function",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2019P001434-1,Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey,Completed,Observational,Other,,Non-Probability Sample,No,No
PMPS 1,Incidence and Factors Affecting the Development and Outcome of Post Mastectomy Pain Syndrome,Not yet recruiting,Observational,Case-Control,,Probability Sample,No,No
2000031319,The In4M Study: Integrating 4 Measures to Assess Physical Function in Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
ICO-2020-22,"Breast Reconstruction by Exclusive Lipomodulin : Feasibility, Evaluation of the Aesthetic Result and Quality of Life",Completed,Observational,Cohort,,Non-Probability Sample,No,No
ERC#2020-3379-10190,Outcomes of Local Perforator Flaps in Oncoplastic Surgery,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
21-055,Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
1955K,Multicentric Risk Evaluation of Autologous Fat Grafting Procedure,Unknown status,Observational,Case-Control,,Non-Probability Sample,No,No
UPCC 21220,CTNNA1 Familial Expansion Study,Recruiting,Observational,Cohort,1 Year,Non-Probability Sample,No,No
MAGREES,Effectiveness and Safety of Preoperative Magnetic Detection of Non-palpable Breast Lesions,Completed,Observational,Cohort,,Non-Probability Sample,No,No
9778,MRI Characterization of Mammographically Detected DCIS,Recruiting,Observational,Cohort,,Non-Probability Sample,No,Yes
TRV-002,Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
KND-QX-CXXT,Clinical Study of Vascular Imaging Evaluation of Computed Tomography Photoacoustic Breast Imaging System,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
ALTERTASTE,Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
Pro00052823,Tissue Expansion in Breast Reconstruction Without Drains,Completed,Observational,Case-Only,,Non-Probability Sample,No,Yes
CIRCADIAN,Chemotherapy-induced Circadian Rhythm Disruption,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Real-HER2,Real World Study on the Efficacy and Safety of Anti-HER2 Therapy,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
19SM5221,Development and Validation of a Tumour Oxygenation Monitoring Probe,Unknown status,Observational,Other,,Non-Probability Sample,No,No
PUMA-NER-9501,HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib,Terminated,Observational,Cohort,,Non-Probability Sample,No,Yes
DWI breast cancer,Diffusion Magnetic Resonance Imaging in Mamographically Detected Asymmetric Densities,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
0141-19-RMB,Characterization of Skin Microbiome Profile and its Correlation to Radiation Dermatitis,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
2021P000209,Mapping and Quantifying Lymphatic Drainage of the Arms Alternate Pathway,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
IRB 22-211,Global Cardio Oncology Registry,Recruiting,Observational,Cohort,18 Months,Non-Probability Sample,No,No
CONFIDENCE-01,CONFIDENCE Registry,Enrolling by invitation,Observational,Other,2 Years,Probability Sample,No,Yes
18-00684,Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP),"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
2019(S073),Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Breast Nodules,Unknown status,Observational,Case-Only,,Non-Probability Sample,No,Yes
OSU-21198,Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery,Completed,Observational,Cohort,,Non-Probability Sample,No,No
018-781,DWIBS-MRI: An Adjunct to the Traditional Diagnostic Breast Imaging Evaluation,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
NCC2962,Multi-center Study of Deep Learning AI in Breast Mass,Recruiting,Observational,Other,,Probability Sample,No,No
CLINP-001013,Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
ICO-2021-05,"Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
735CLD Rev.04,The ClearCoast™ Magnetic Resonance Outcome PMS Study,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CLP-0004,A Retrospective Breast Reconstruction Study,Completed,Observational,Cohort,,Non-Probability Sample,No,No
APHP220816,Cognitive Processing Slowness as a Marker of Cognitive Impairment in Non-central Nervous System Cancer Patients,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
GOG-8023,Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,,
PSG SOMAVAC,Evaluation of SOMAVAC 100 Sustained Vacuum System,Completed,Observational,Case-Only,,Non-Probability Sample,No,Yes
FMSU2017-003,Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing,Completed,Observational,Case-Crossover,,Non-Probability Sample,No,Yes
PER-19-03,Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue.,Completed,Observational,Cohort,,Probability Sample,No,Yes
ETNA-CRCI,Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI),Recruiting,Observational,Cohort,,Probability Sample,No,No
2019-A00121-56,Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure,"Active, not recruiting",Observational,Cohort,26 Months,Non-Probability Sample,No,No
2018-9409,Intra-Operative Radiation Registry,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
2020-0980,What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2019P003607-11,Data Analysis for Drug Repurposing for Effective Alzheimers Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,Yes,No
19-005445,Determining Molecular Drivers of Radiation Dermatitis,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
2020-3,Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System,Recruiting,Observational,Case-Crossover,,Non-Probability Sample,No,No
CIRB Ref. No: 2017/3139,Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
LCCC1754,UNC Pleural Fluid Registry,Recruiting,Observational,Cohort,32 Years,Non-Probability Sample,No,No
Tomosymthesis,Tomosymthesis for Breast Mass Lesion Characterization,Not yet recruiting,Observational,Case-Only,,Probability Sample,,
BCA-AI,Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography,Completed,Observational,Cohort,,Probability Sample,No,No
20190701041GH,Antler Plate on Preventing Mammary High-risk Lesions From Malignant Development,Recruiting,Observational,Cohort,1 Year,Non-Probability Sample,No,No
CMUH106-REC2-117,Evaluation of the Efficacy of Acupuncture in Chemotherapy Induced Peripheral Neuropathy,Unknown status,Observational,Case-Control,,Probability Sample,No,No
2019-06214,Psychological Effects of Implant Loss,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
v24-9-2017,Psyhosomatic Medicine in Oncologic and Cardiac Disease Study,Unknown status,Observational,Case-Control,5 Years,Non-Probability Sample,No,No
Ageing-NIO,"Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization Techniques",Recruiting,Observational,Cohort,,Probability Sample,No,No
DPCVC,Diagnostic Power Comparison Between VOCs and CTCs,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
0S-20-6,Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
SRNSM,"Examining the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Skin Reducing Nipple Sparing Mastectomy and Implant Based Breast Reconstruction, and Comparing it to Classic Skin- Sparing Mastectomy and Implant- Based Breast Reconstructive Surgeries",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PI-3958,Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit?,Completed,Observational,Case-Control,,Non-Probability Sample,Yes,No
06-2020/1,Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
4-2019-0834,Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate Reconstruction,"Active, not recruiting",Observational,Case-Control,,Non-Probability Sample,No,No
P050001 TiLOOP® Bra Pocket,Post Market Clinical Follow Up to Patient Reported Outcome Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket),"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
1049/2018,Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy,Completed,Observational,Cohort,,Non-Probability Sample,No,Yes
2012285106,Dedicated Breast CT for Quantitative Breast Density Measurements in Mexican-origin Women in Southern Arizona,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
BREAST HEMATOMA,Vacuum-Assisted Evacuation (VAE) Of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries And Percutaneous Procedures: a Retrospective Analysis,Completed,Observational,Other,,Non-Probability Sample,No,Yes
D161100000816006,Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion,Completed,Observational,Cohort,,Probability Sample,No,No
226947,SS-INQ Information Needs Questionnaire in Sjögrens Syndrome,Completed,Observational,Other,,Non-Probability Sample,No,No
15/LO/1038 BRACELET,Breast: Recovery After Axillary Node Clearance - Evaluating Limbs With E-Technology (the BRACELET Study),Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
NCCH1905,Asian Multicenter Prospective Study of ctDNA Sequencing,Recruiting,Observational,Cohort,,Probability Sample,No,No
RocuMAST,Effect of Rocuronium on BIS Values,Recruiting,Observational,Cohort,,Probability Sample,No,No
1920306,Purpose in Life Survey,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
2022-01423-01,Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP),Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
Breast 2019,PCR Based CEUS in BI RADS 4A Nodules,Unknown status,Observational,Cohort,,Probability Sample,No,No
2021-082,DIEP Flap Surgery and Intraabdominal Pressure,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
18232,Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
4-2020-0165,Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
IRB#56402,Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
APHP210583,Personalized Estimation of Doses Delivered During Image Guided Radiation Therapy Tests,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
202202104,Implementation of a Health System Intervention to Improve Quality of Cancer Care for Rural Patients,Recruiting,Observational,Other,,Non-Probability Sample,No,No
2019/629,Breast Density Measurements in Digital Mammography and Breast Tomosynthesis Systems of Different Pixel Size,Unknown status,Observational,Cohort,,Non-Probability Sample,No,Yes
RB-vs-RG-BCS,"Comparison of the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Round-block and Retroglandular Oncoplastic Breast Conserving Surgeries",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
RIPH3-RNI18/NEUROTAX,Involvement of SK3 Calcium Channel in Taxane Neuropathy,Completed,Observational,Cohort,,Probability Sample,No,No
2021-PrMa-RWiberg,"Prophylactic Mastectomy: Prospective Evaluation of the Correlation Between Skin Flap Thickness, Residual Glandular Tissue and Skin Necrosis by Imaging and Clinical Examination",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
69HCL20_0346,Impact of the COVID-19 Pandemic in Gynecological Oncology,Completed,Observational,Case-Control,,Non-Probability Sample,No,No
TJ-IRB20211129,68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients,Recruiting,Observational,Other,2 Years,Non-Probability Sample,No,No
69HCL19_0731,"Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis",Completed,Observational,Cohort,,Non-Probability Sample,No,No
EAQ161CD,Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting,"Active, not recruiting",Observational,Ecologic or Community,,Non-Probability Sample,,
G-5097-2019,Evaluation of Postoperative Nausea and Vomiting Incidence in Patients With Mastectomy Surgery According to Apfel Risk Scoring System,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
NIMAO/2016/PC-01,Kinetics of Perioperative Circulating DNA in Cancer Surgery,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
IIT-2021-CANINE,To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment,"Active, not recruiting",Observational,Case-Only,,Probability Sample,No,No
2018P000084,Evaluation of ADM Soft Tissue Reinforcement,Unknown status,Observational,Cohort,,Non-Probability Sample,No,Yes
NIP IT!,Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
PRO 1676,A Digimed Oncology PharmacoTherapy Registry,Unknown status,Observational,Other,,Probability Sample,No,No
69HCL17_0642,Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
PVMEDCT202201,Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk,Recruiting,Observational,Cohort,,Probability Sample,No,No
SAHZhejiangU 123,Added Value of Contrast-enhanced Ultrasound for BI RADS 4A Nodules,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
CCR5653,Accelerated Body Diffusion-Weighted MRI Using Artificial Intelligence,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
1190532,Chilean Maternal & Infant Cohort Study II (CHiMINCs-II),"Active, not recruiting",Observational,Cohort,,Probability Sample,No,No
2017-02028,Efficacy of the Consilium Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients,Terminated,Observational,Cohort,,Probability Sample,No,No
JS001-PMS-CO1,Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
Pro00037562,Apple Womens Health Study,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
829785,Effect of PARP Inhibitors on Glomerular Filtration Rate,Terminated,Observational,Cohort,,Non-Probability Sample,No,No
IRB 20-488,CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
20,Early Detection of Heart Problems in Cancer Patients Receiving Chemotherapy,Withdrawn,Observational,Case-Only,,Non-Probability Sample,No,No
209514,Pilot Study of Pancreatic Cancer Screening,Recruiting,Observational,Cohort,,Probability Sample,No,No
Klotho _ LRP-6 _ GC,Klotho _ LRP-6 _ Gastric Adenocarcinoma,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
20/PR/0222,Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing,"Active, not recruiting",Observational,Cohort,,Probability Sample,No,No
GOUDET 2018,Study and Monitoring of Multiple Endocrine Neoplasia Type 1,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
FF-2018-084,Does Pecs II Block Reduce the Incidence of Post Mastectomy Pain Syndrome (PMPS)? A Cross Sectional Study,Completed,Observational,Cohort,2 Years,Probability Sample,No,No
2018-03,SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY,Unknown status,Observational,Case-Control,,Probability Sample,No,No
P2101,The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing,Recruiting,Observational,Cohort,10 Years,Non-Probability Sample,No,Yes
201903142,Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2021-04840,Lymphedema After Urologic Surgery,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Niraparib-5001,A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
LINDA,Study To Evaluate The Sensitivity Of The Linda Thermal Device,Recruiting,Observational,Cohort,,Probability Sample,No,No
B3271007,Safety and Efficacy of Trastuzumab BS,Not yet recruiting,Observational,Case-Only,,Probability Sample,Yes,No
Soh-Med-22-09-01,Ultrasonography Screening for Breast Lesions During Pregnancy and Lactation,Not yet recruiting,Observational,Case-Only,,Probability Sample,No,No
OCOG-2021-ELISA,Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS),Recruiting,Observational,Cohort,,Probability Sample,No,No
CHIRCOLREC-IPC 2018-017,Prospective Database for Colonic or Rectal Resection Surgery Patients,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
49/20 b,Breast Reconstruction in Previously Irradiated Breast,Completed,Observational,Case-Control,,Probability Sample,No,No
ROR2103,"Evaluating Patient Reported Outcomes in Radiation Therapy, The PRO-RT Study",Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
KY-2021-012,A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2,Not yet recruiting,Observational,Other,1 Year,Non-Probability Sample,No,No
49/20,Adjuvant Radiotherapys Effect on One and Two Stages Prosthetic Breast Reconstruction and on Autologous Reconstruction,Completed,Observational,Case-Control,,Probability Sample,No,No
Pro00054854,The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
38RC17.291,EssaiClinique_CBSM,Terminated,Observational,Case-Control,,Non-Probability Sample,No,No
034-2020,Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
228-17-EP,Chemotherapy-Related Changes in Neurocognitive Function and Symptoms in Colorectal Cancer Patients: A Pilot Study,Completed,Observational,Cohort,,Non-Probability Sample,No,No
2019-8890,Clinical Evaluation of CEM-guided Biopsy,Completed,Observational,Case-Only,,Non-Probability Sample,No,Yes
2021-KY-073,The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study,Recruiting,Observational,Cohort,,Probability Sample,No,No
EXGEFATU,"Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes",Recruiting,Observational,Cohort,,Probability Sample,No,No
FESPET,FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment,Unknown status,Observational,Case-Only,,Non-Probability Sample,No,No
ILYAD1_2019,Initiative in LYon for Lung cAncer Screening Development - Prevalence Study,Completed,Observational,Ecologic or Community,,Non-Probability Sample,No,No
919/2020/Oss/IOR,"Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma",Recruiting,Observational,Case-Control,4 Years,Non-Probability Sample,No,No
BARBEN 2020,Impact of Age and Geriatric Co-morbidities on Lymphocyte Phenotype in Patients 70 Years of Age and Older,Withdrawn,Observational,Cohort,,Non-Probability Sample,No,No
Soh-Med-22-09-16,Role of IMP3 Expression in Colorectal Carcinoma: An Immunohistochemical Study,Recruiting,Observational,Other,5 Months,Non-Probability Sample,,
Shengjing-LJY05,The Effect of Gravity on the Occurrence of Lactational Mastitis,Recruiting,Observational,Cohort,,Probability Sample,No,No
PREDICT,The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor,"Active, not recruiting",Observational,Case-Only,,Non-Probability Sample,No,No
CHU-426,Evaluation by Oncologists of Strategies for the Prevention and Treatment of Chemotherapy-induced Peripheral Neuropathies,Completed,Observational,Cohort,,Non-Probability Sample,No,No
IRAS307166,How Does Skin Tone Affect Quantitative Photoacoustic Imaging,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
999916161,The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk Tradeoffs,Withdrawn,Observational,Other,,Non-Probability Sample,,
1000-1,Womens Assessed Cardiovascular Evaluation With MCG,Completed,Observational,Cohort,,Non-Probability Sample,No,Yes
R-17-360,Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
BIC4VMR,Breakthrough Improvement Collaborative for Ventral Mesh Rectopexy,Not yet recruiting,Observational,Other,,Non-Probability Sample,No,No
19CX5601,PROState Pathway Embedded Comparative Trial,Completed,Observational,Other,,Probability Sample,No,No
APHP180576,18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
IEO 1740,68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET,Recruiting,Observational,Other,,Probability Sample,No,No
Soh-Med-22-03-01,IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag Governorate,Recruiting,Observational,Other,,Non-Probability Sample,No,No
2019-02Obs-CHRMT,Psychological Determinants of the Therapeutic Observance of Osteoporotic Patients,Completed,Observational,Cohort,,Non-Probability Sample,No,No
ShuangHoH,Smart Home Care of Cloud Base ECG on the Cardiotoxicity Prevention on the Cancer Patients.,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
CMUH109-REC2-101,Evaluation of the Efficacy of Chinese Herbal Medicine in Patients With Obesity,Unknown status,Observational,Cohort,,Probability Sample,No,No
RNI 2021 LEBRETON 3 (EVIGE),Evaluation of the Inter-center Variability of the Measurement of Thrombin Generation by the ST Genesia System,Recruiting,Observational,Case-Control,,Probability Sample,No,No
1648/2019,"Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases",Recruiting,Observational,Cohort,6 Months,Non-Probability Sample,No,No
22072,A Study Called GUS to Understand How Much of the Contrast Agent Gadavist is Used and How Much is Wasted in Two Different Containers (Single-dose Vials and Imaging Bulk Packages ) in a Real-world Setting,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
HKG-KZ-PRAD-103,"Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC",Withdrawn,Observational,Case-Control,,Probability Sample,No,No
PET/CT in malignancy,Validity of Mediastinal Blood Pool SUV Ratio,Not yet recruiting,Observational,Cohort,,Probability Sample,No,Yes
AssiutNT,Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer,Recruiting,Observational,Case-Only,,Probability Sample,No,No
HKG-Bng-HCC-100,HCC Screening Using DNA Methylation Changes in ctDNA,Completed,Observational,Case-Control,,Non-Probability Sample,No,No
IX-2021-DS-LEARN,LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
Pro00101102,Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions,Terminated,Observational,Cohort,,Non-Probability Sample,No,No
NL66650.041.18,The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study,Recruiting,Observational,Cohort,2 Years,Non-Probability Sample,No,Yes
HALO Dx 001,Phase I Human Analytics (HALO) Study,Recruiting,Observational,Cohort,,Non-Probability Sample,No,Yes
SYSU_AI01,Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics,Unknown status,Observational,Cohort,2 Years,Non-Probability Sample,No,No
B2017-113R,Tumor Landscape Pathological Diagnosis by Large Tissue Sections,Unknown status,Observational,Case-Control,3 Years,Non-Probability Sample,No,No
STU-2019-0522,Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM),Completed,Observational,Cohort,,Probability Sample,,
PJ-KS-KY-2019-134,The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients,Unknown status,Observational,Cohort,,Probability Sample,No,No
DMT-2019.002,Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3),Completed,Observational,Case-Control,,Probability Sample,No,Yes
DMT-2019.001,Delphinus SoftVue™ ROC Reader Study,Completed,Observational,Case-Control,,Probability Sample,No,Yes
AD10,KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method),Not yet recruiting,Observational,Case-Control,1 Month,Probability Sample,No,No
CASE7Y16,A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors,Completed,Observational,Cohort,,Probability Sample,No,Yes
LOCAL/2020/DR-01,18F-DOPA-PET in Non-tumoral and Tumoral Brain Lesions,Completed,Observational,Cohort,,Probability Sample,No,No
PJ-KS-KY-2019-135,"Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy",Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
D0817R00010,OLAP (OLAparib Regulatory Post-marketing Surveillance),Recruiting,Observational,Cohort,,Non-Probability Sample,,
201610,Predicting Chronic Pain Following Breast Surgery,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
PREDAPT,A Multicenter Cancer Biospecimen Collection Study,Recruiting,Observational,Case-Only,,Probability Sample,No,No
HH-PRT-0001,Development and Validation of Harbinger Health Test for Early Cancer Detection,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
AD07,GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method),Not yet recruiting,Observational,Case-Control,1 Month,Probability Sample,No,No
123glioma,Correlation Between SPECT/CT and IDH Mutation in Brain Glioma,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
NCH04-2020,"Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery",Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
BakircayU/D208,Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function,Completed,Observational,Cohort,,Non-Probability Sample,No,No
D0818R00008,A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2000028592,Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
22/006-P,Palliative Care Costs for Outpatient Setting Management in Catalunya,Not yet recruiting,Observational,Other,1 Month,Non-Probability Sample,No,No
PREFER,PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine,Recruiting,Observational,Cohort,2 Years,Probability Sample,,
M18HAR,Health After eaRly Menopause Due to Oophorectomy,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
8259,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,Recruiting,Observational,Cohort,,Probability Sample,,No
20-458,Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
M20COM,The Prospective Observational COMPRAYA Cohort Study,Recruiting,Observational,Cohort,10 Years,Non-Probability Sample,No,No
S1714,Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,,
2020/2706,Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes,Completed,Observational,Cohort,,Probability Sample,No,No
Pro00077309,Prevent Cancer- Greenville,Recruiting,Observational,Ecologic or Community,,Non-Probability Sample,No,No
105909,Influence of Chemotherapy on Postural Control in Women With Cancer,Recruiting,Observational,Cohort,,Probability Sample,No,No
19ON033,Vibrational Spectroscopy for Endometrial Cancer Diagnosis,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
Parameters of resistence,Parameters Declaring PCO Infertile Patients Either Sensitive or Resistant to Different Doses of Clomiphene Citrate.,Recruiting,Observational,Cohort,3 Months,Probability Sample,No,No
NCI-2018-01375,"Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study","Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
A212102,Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
IRB00058758,Paclitaxel Therapeutic Drug Monitoring in Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
2019-0239,Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
180043,Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy,Terminated,Observational,Cohort,,Non-Probability Sample,No,No
INT 48/21,Quantifying Systemic Immunosuppression to Personalize Cancer Therapy,Recruiting,Observational,Case-Control,,Probability Sample,No,No
DV001,The Effect of Androgen Receptor Polymorphism on Endometrial Cancer,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
IIBSP-ECV-2019-103,Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT),Recruiting,Observational,Case-Control,,Non-Probability Sample,,
Pro9646,Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
INT156-19,Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment,Completed,Observational,Cohort,,Non-Probability Sample,No,No
02-MX-003,ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation,Recruiting,Observational,Cohort,,Probability Sample,No,No
09.2018.466,Reliability of Subcutaneous Echogenicity (SEG) Grade and Subcutaneous Echo-free Space (SEFS) Grade,Completed,Observational,Other,,Probability Sample,No,No
IB2022-02,Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
0S-17-4,"Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer",Withdrawn,Observational,Case-Only,,Non-Probability Sample,No,No
AS-IRB-BM-17056,Taiwan Cancer Moonshot Project,Recruiting,Observational,Cohort,4 Years,Probability Sample,No,No
SYNERGY-AI,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry,Recruiting,Observational,Cohort,36 Months,Non-Probability Sample,No,No
Adela-EDMRD-001,cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease,Recruiting,Observational,Case-Control,,Non-Probability Sample,No,No
Cancer Genetic Counseling.PSI,Assessment Psychological Distress for Cancer Heredity Test,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
11190071,Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients,"Active, not recruiting",Observational,Cohort,3 Months,Non-Probability Sample,No,No
TRV-003,Mass Response of Malignant Fluid Cells as a Biomarker for Rapid Therapy Guidance,Recruiting,Observational,Cohort,,Probability Sample,No,No
HSP70CTC,Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells,Recruiting,Observational,Cohort,3 Months,Probability Sample,No,No
MOHCCN-O,Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
STU00209558,Plan to Thrive: Extending Cancer Survivorship Care Beyond the Clinic,Completed,Observational,Cohort,,Non-Probability Sample,No,No
TP-CA-001,Tempus Priority Study: A Pan-tumor Observational Study,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
202211038RINA,Microscopy Imaging of Whole-mount Stained Human Tissues,Not yet recruiting,Observational,Case-Control,5 Years,Non-Probability Sample,No,No
HREBA.CC-22-0196,LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study,Recruiting,Observational,Family-Based,,Non-Probability Sample,No,No
AVS4TL - 0921,Avera/Sema4 Oncology and Analytics Protocol,Recruiting,Observational,Other,,Probability Sample,No,No
DPM401,Study to Evaluate the Safety of Nanoxel M Inj.,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
BR-DTX-OS-401,Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor,Completed,Observational,Cohort,,Non-Probability Sample,No,No
APHP190973,Integrated Care Pathway in Oncology (PASSION),"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
202100484,Early Ageing During Therapy in AYA Cancer Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
MX-011-219,Project CADENCE (CAncer Detected Early caN be CurEd),Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
R231-A14057,Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.,Completed,Observational,Other,6 Months,Non-Probability Sample,No,No
ROOT,The Registry of Oncology Outcomes Associated With Testing and Treatment,Recruiting,Observational,Cohort,5 Years,Non-Probability Sample,No,No
MYCT001,The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology),Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
05-2019,Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
PN #1082409C,Post Market Clinical Follow-up Study on da Vinci® Robotic-assisted Prophylactic Nipple Sparing Mastectomy With Breast Reconstruction,Recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2011P002580-207,Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer Endpoints,Completed,Observational,Cohort,,Non-Probability Sample,Yes,No
FT-003,"Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy",Recruiting,Observational,Case-Only,,Non-Probability Sample,Yes,
SAHoWMU-CR2021-02-404,Gastric Cancer Marker Detection and Its Kit Development,Recruiting,Observational,Cohort,1 Day,Probability Sample,No,No
7101,Womens Knowledges About Gynaecological Aftercare,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
200-04,A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
01GS,Early Detection of Five Common Cancers Using the ctDNA Analysing Test,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
19-110,Minnesota Care Coordination Effectiveness Study,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
17-01135,Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome,Recruiting,Observational,Family-Based,,Probability Sample,No,No
2019-00134,Vitamin D3 - Omega3 - Home Exercise - HeALTHy Aging and Longevity Cohort,Enrolling by invitation,Observational,Cohort,,Non-Probability Sample,No,No
19-007,DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement,Withdrawn,Observational,Cohort,,Probability Sample,No,No
2018-01B,Stool Collection Sub-Study of Exact Sciences Protocol 2018-01,Completed,Observational,Cohort,,Non-Probability Sample,No,No
IOSI-COVID19-001,A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study,Completed,Observational,Case-Only,,Non-Probability Sample,No,No
GOG-8030,Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199,Not yet recruiting,Observational,,,Non-Probability Sample,,
18HLGENE03,Evaluation of the Adhesion to the GENEPY Network,Unknown status,Observational,Ecologic or Community,1 Day,Non-Probability Sample,No,No
CR108454,A Study of Participants With Advanced Prostate Cancer in Canada,"Active, not recruiting",Observational,Cohort,,Non-Probability Sample,No,No
MO19/127559,Tolerance of Anti-Cancer Therapy in the Elderly,Recruiting,Observational,Cohort,,Probability Sample,No,No
RPCR-breast 01,Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT),Recruiting,Observational,Case-Only,5 Years,Non-Probability Sample,No,No
WP-2021-03,Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy,Not yet recruiting,Observational,Cohort,,Probability Sample,No,No
FatebenefratelliH,Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging,Recruiting,Observational,Case-Only,5 Years,Non-Probability Sample,No,No
2019P001434-2,Examining Validity and Reliability of the Shared Decision Making Process Survey in Adults With Depression,Completed,Observational,Other,,Non-Probability Sample,No,No
BC 09915,Lymphedema After Gyneco-oncologic Treatment,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
7013,MRI in Ductal Carcinoma in Situ (DCIS),Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
22-200,"InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer",Not yet recruiting,Observational,Cohort,20 Years,Probability Sample,No,No
20172841,The PREDICT Registry for DCIS Patients With DCISionRT Testing,Suspended,Observational,Cohort,10 Years,Non-Probability Sample,No,Yes
RC31/18/0440,Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBase,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
SDLNOC,Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
2021-1211,Development of an Application-Based Digital Navigator for Perioperative Breast Surgery Patients,Recruiting,Observational,Cohort,,Probability Sample,No,No
LSHBSWMBC,Screening of Cancer Through Novel Female Specific Biomarkers,Unknown status,Observational,Case-Control,,Non-Probability Sample,No,Yes
1655,Cell-free DNA in Hereditary And High-Risk Malignancies,Recruiting,Observational,Cohort,,Probability Sample,No,No
Colorectal Cancer,Colorectal Cancer Awareness in Turkey,Unknown status,Observational,Other,,Non-Probability Sample,No,No
1992110-1,Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education,Recruiting,Observational,Other,,Non-Probability Sample,No,No
CSC-20200324,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,Unknown status,Observational,Cohort,,Non-Probability Sample,No,No
0029-20-ZIV,Smurf2 Gene Expression in Urinary Tract Tumors,Not yet recruiting,Observational,Cohort,,Non-Probability Sample,No,No
HKG-KZ-LNG-102,Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA,Terminated,Observational,Case-Control,,Non-Probability Sample,No,No
LIFT project,Longitudinal Investigation of Cancer-related Fatigue and Its Treatment (LIFT Project),Recruiting,Observational,Cohort,,Probability Sample,No,No
2019-PVSEP,Drugs for the Treatment of Multiple Sclerosis and Risk of Cancer: a Pharmacovigilance Analysis in Vigibase,Unknown status,Observational,Case-Control,,Non-Probability Sample,No,No
002.1,Telegenetics or In-Person Genetic Counselling,Recruiting,Observational,Cohort,,Non-Probability Sample,No,No
LIFT,Longitudinal Investigation of Cancer-related Fatigue,Withdrawn,Observational,Cohort,,Probability Sample,No,No
2767,The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer,Recruiting,Observational,Cohort,2 Years,Probability Sample,No,No
09.2019.1026,Prognostic Value of Body Composition in Lung Cancer,Completed,Observational,Cohort,,Non-Probability Sample,No,No
EC/GOVT/24/IRB23,Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO ),Completed,Observational,Case-Only,,Non-Probability Sample,No,No
CFTSp195,A Survey Exploring Health and Screening Tests in People Treated for Hodgkin Lymphoma,Completed,Observational,Cohort,,Non-Probability Sample,No,No
04/20,Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer,Recruiting,Observational,Cohort,,Probability Sample,Yes,No
MRI in urinary bladder tumors,Role of MRI in Assessment of the Urinary Bladder Wall Post Transurethral Tumor Resection,Not yet recruiting,Observational,Case-Only,,Non-Probability Sample,No,No
2018PS02,Pharmacist and Data Driven Quality Improvement in Primary Care,Completed,Observational,Ecologic or Community,,Non-Probability Sample,No,No
